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ABSTRACT

AN ACYL RADICAL CASCADE MODEL FOR THE
TOTAL SYNTHESIS OF LYCONADIN A

Seth Wilson Grant
Department of Chemistry and Biochemistry
Master of Science
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Lyconadin A (1) is a structurally unique Lycopodium alkaloid with antitumor
properties, isolated from the club moss Lycopodium complanatum. We are developing a
synthetic route to 1 based on a novel 7-exo-trig/6-exo-trig acyl radical cascade
cyclization. The synthesis of model acyl radical cascade precursor 23 will be presented.
Key features of this synthesis include the suppression of competing elimination during
the alkylation of a hindered phenethyl bromide and the use of a lactone as a precursor to a
compound bearing two differentially protected primary alcohols. An account of our

studies on the model acyl radical cascade cyclization (23 → 24 above) will also be given,
including a stereochemical analysis of the product. Our findings have been applied to
develop a more detailed stereoselective synthetic plan for Lyconadin A (1).
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CHAPTER 1. INTRODUCTION
1.1 Lyconadin A
The alkoloid Lyconadin A (1, Figure 1) was recently isolated from the club moss
Lycopodium complanatum and fully characterized by Kobayashi and co-workers.1 Its
structure was determined by a combination of HRMS, IR, and 2-D NMR techniques.
The novel bridged pentacyclic skeleton of Lyconadin A consists of an α-pyridone ring, as
well as one five-membered and three six-membered rings. It also contains six
stereocenters. In addition to its novel architecture Lyconadin A also exhibits in vitro
cytotoxicity against two cancer cell lines: murine lymphoma L1210 cells (IC50 = 0.46
μg/mL) and human epidermoid carcinoma KB cells (IC50 = 1.7 μg/mL).1 Despite its
appealing structure and biological activity, to date Lyconadin A has not been synthesized,
and only one possible approach to its synthesis has been reported.2
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Figure 1. Lyconadin A (1)

1.2 Lycopodium Alkaloids
Lyconadin A belongs to the lycopodium alkaloid family, a diverse group of
natural products generally consisting of sixteen carbon and one or two nitrogen atoms,
with various degrees of oxygenation. They are presumably derived from two
2-propylpiperidine subunits (thus the numbering in Figure 1). Ma and Gang recently

1

reviewed3 the chemical, pharmacological, and clinical research being performed on this
family of alkaloids, and several previous reviews exist as well.4,5
The lycopodium family is often divided into four classes based on their structural
skeletons.3 These classes are the Lycodines, the Lycopodines, the Fawcettimines, and a
Miscellaneous class. A typical example from each of these classes is shown in Figure 2
(Phlegmarine is the example from the miscellaneous class). Although the biosynthesis of
the lycopodium alkaloids is not completely understood, it is thought that Phlegmarine (2),
in which the two 2-propylpiperidine subunits are more obvious, is the common precursor
to all classes of the Lycopodium alkaloids. Thus, bond formation between C-4 and C-13
of Phlegmarine yields the Lycodine skeleton (3). From Lycodine, disconnection of the
C-1–Nα bond, and reconnection of C-1 to Nβ gives the Lycopodine structure (4). From
there, migration of C-4 from C-13 to C-12 reveals the Fawcettimine (5) skeleton.
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Figure 2. Classes of Lycopodium Alkaloids

Many members of the lycopodium alkaloid family are biologically active. For
example, an exclusive feature of many compounds in the Lycodine subclass is their
ability to inhibit acetylcholinesterase.6,7 Of these, Huperzine A (6, Figure 3) is the most
potent.8,9 It has been shown that due to its strong inhibition of acetylcholinesterase it
increases memory and learning efficiency in mammals,8,9 and shows promise in the
treatment of Alzheimer’s disease and myasthenia gravis.10,11 Huperzine A and a Schiff

2

base derivative of Huperzine A named ZT-1 are currently in clinical trials for use as a
treatment for Alzheimer’s disease.3
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Figure 3. Huperzine A (6)

It is proposed that Lyconadin A, a member of the miscellaneous class (Figure 2)
and all other lycopodium alkaloids are derived biologically from two 2-propylpiperidine
moieties via Phlegmarine (2). The proposed biosynthesis3 of Lyconadin A is shown in
Scheme 1. Decarboxylation of L-lysine gives Cadaverine (7), which upon oxidation and
imine formation gives Δ1-Piperideine (8). Meanwhile, Malonyl-CoA (9) can undergo
self-condensation followed by decarboxylation to give 10 (X = OH or SCoA). Addition
of this acetone derivative to 8, again followed by decarboxylation, gives 4PAA or
4PAACoA (11 or 12), which is hydrolyzed (if necessary) and yet again decarboxylated to
give Pelletierine (13). Condensation of 11 or 12 with Pelletierine, decarboxylation, and
ring closure affords Phlegmarine (2), the intermediate thought to be the diverging point
for all Lycopodium alkaloids. From there, epimerization of C-13 and oxidation of the A
ring to an α-pyridone (14), followed by C-6–Nβ and C-4–C-10 bond formation gives
Lyconadin A, 1. This proposed biosynthesis is supported up through Phlegmarine (2) by
feeder studies.3
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Scheme 1. Proposed Biosynthesis of Lyconadin A

1.3 Synthetic Approach to Lyconadin A
Any total synthesis of 1 would be faced with the task of constructing the
pentacyclic ring system. Our approach to this challenge is shown in retrosynthetic form
in Scheme 2. We propose that a one-pot double-intramolecular-reductive amination
could form two of the C–N bonds simultaneously. In the reverse direction, protection
and disconnection of the C-13–N and C-6–N bonds reveals 15, which consists of a
bicyclo[5.4.0]undecane ring system, fused to a pyridone. We believe this ring system can
be achieved via a tandem 7-exo-trig/6-exo-trig radical cascade reaction of the acyl radical
generated from phenyl selenoester 16. This reaction represents a novel radical cascade
system. Should this proposed reaction not give the appropriate stereochemistry,
modifications to 16 could allow for stereoselective installation of the requisite
stereocenters. Compound 16 in turn could be formed in a convergent manner from the
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stereoselective addition of the cuprate derived from bromide 18 with the known12 chiral
epoxy alcohol 17, according to Hamada’s procedure,13 followed by standard
transformations. A close analogue of 18 would be readily available from compound 19,
methyl propiolate, and ammonia via Kozikowski’s pyridone synthesis.14 α-Keto ester 19
could be prepared by the Horner–Emmons reaction of known15 phosphonate 20 with
aldehyde 21, which should in turn be available from triol 22 via an enzymatic
asymmetrization.16
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Scheme 2. Retrosynthesis of Lyconadin A

The key step in our proposed synthesis of Lyconadin A is the acyl radical cascade
cyclization (16 → 15, Scheme 2). This proposed novel radical cascade reaction
represents a significant risk at such a late stage in the total synthesis. Consequently, it
would be wise to evaluate the feasibility and stereoselectivity of this reaction on a simpler
substrate, such as phenyl selenoester 23 (Scheme 3), prior to applying it in the total
synthesis. This phenyl selenoester will serve as an adequate model for the desired radical
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cascade cyclization step because it contains the key components of 16 in the proper
relative positions, and should be easier to prepare. Scheme 3 shows the mechanism we
expect to be operative in the model cascade reaction. Treatment of phenyl selenoester 23
with either stannyl or silyl radicals should generate an acyl radical. We anticipate that
this acyl radical will add in a 7-exo fashion across the first alkene, and that the newly
generated primary radical will subsequently add to the second alkene in a 6-exo manner.
Propagation of the chain should provide 24, which, to the best of our knowledge, will
demonstrate the first application of an acyl radical cascade reaction to prepare the
bicyclo[5.4.0]undecane ring system. The goal of my project is to synthesize phenyl
selenoester 23 and use it to explore this proposed acyl radical cascade. Based on the
regio- and stereochemical results of the model study, we will develop a more detailed
synthetic route to Lyconadin A.
SePh
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O
stannyl or silyl radicals
OTBS

OTBS
Model Phenyl Selenoester 23

O

24

O

O
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OTBS
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Scheme 3. Mechanism of the Proposed Acyl Radical Cascade

Upon inspection of compound 23 one will immediately note the absence of
defined stereochemistry. We hope to investigate the possibility of substrate control on
the stereoselectivity of the two new stereocenters formed in the radical cascade. To fully
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explore this aspect of the reaction we need both diastereomers of phenyl selenoester 23.
Thus, its synthesis should allow for formation and separation of the two diastereomers as
racemic mixtures. A thorough investigation of this novel acyl radical cascade on each
diastereomer will provide not only confirmation of the feasibility of the proposed radical
cascade, but will also supply valuable information about the degree of stereoselectivity
that can be expected when this reaction is applied in the total synthesis. Should the
stereoselectivity be poor, we will attempt to incorporate appropriate functionality into
compound 16 (Scheme 2) during the total synthesis that will allow us to define the
appropriate stereochemistry following the radical cascade cyclization. An example of
such a modification is the replacement of the first alkene with an alkyne, thus generating
an enone, which could subsequently be reduced stereoselectively.

1.4 Acyl Radicals
The chemistry of acyl radicals has been thoroughly reviewed by Chatgilialoglu,
Crich, Komatsu, and Ryu17 and the reader is referred to their article for additional details
and a comprehensive list of references. An acyl radical is any compound of the general
formula RC(O)•, in which an unpaired electron occupies a sigma orbital on the sp2hybridized carbonyl carbon. This orbital is orthogonal to the π bond and thus the
unpaired electron is not delocalized, although it is possible that it mixes to some extent
with an electron pair of the oxygen. These structural features give the carbonyl carbon a
bent geometry.
Acyl radicals can be generated in three ways (Scheme 4). The most common
method is the homolytic cleavage of the carbonyl C–X bond (method a). This method is
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known where X is a H, Cl, Br, S, Se, Te, or Co atom. Historically, homolysis of
aldehydes and acyl chlorides was the primary approach to acyl radical generation by this
method, although neither of these processes is known to be highly efficient. However,
aldehydes can form acyl radicals when treated with peroxides, and the efficiency is
increased when the reaction is catalyzed by thiols.18,19 Acyl chlorides can also form acyl
radicals when treated with a radical initiator and a chain carrier, although the stannanemediated reactions face significant complications. A more successful approach employs
(TMS)3SiH as the chain carrier.20 Acyl chlorides also form acyl radicals when treated
with Sm(II) complexes,21,22 although the acyl radical or the resulting products often
undergo further reduction by the samarium. Aryl thioesters (RCOSAr) generate acyl
radicals upon photolysis or vigorous thermolysis,23–25 although they are unreactive26
toward the tributylstannyl radical, which limits their synthetic applicability. Acyl
tellurides27 and acylcobalt(III) complexes28 have been shown to generate acyl radicals
upon irradiation, although they have not found widespread application.
O
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O
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X
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O

c
R

R'

b
RX + CO

Scheme 4. Generation of Acyl Radicals

The most common substrate currently used to generate acyl radicals in organic
synthesis is the phenyl selenoester (RCOSePh), originally developed by Graf and coworkers,29,30 who demonstrated its use as a decarbonylation precursor. Phenyl
selenoesters are the preferred acyl radical precursors because they do not face the
complications that acyl chlorides do, such as isolation, purification by silica gel
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chromatography, and over-reduction. In addition, unlike aldehydes and aryl thioesters,
they react readily with either stannyl or tris(trimethylsilyl)silyl radicals.31 They can be
prepared from the corresponding acyl chlorides using benzeneselenol29,30,32,33 or diphenyl
diselenide34,35 (PhSeSePh). More conveniently however, phenyl selenoesters can also be
prepared from carboxylic acids by employing N-phenylselenophthalimide,36,37
phenylselenyl chloride,38 or diphenyl diselenide.39 Methyl selenoesters are also known
acyl radical precursors; their preparation from O-alkyl esters using dimethylaluminum
methaneselenolate40 and use as acyl radical precursors41 is documented.
The generation of acyl radicals by carbonylation of alkyl radicals (method b,
Scheme 4) has been reviewed by Ryu and Sonoda.42 Alkyl or aryl bromides, iodides, or
selenides are used to generate an alkyl or aryl radical, which then adds to CO. The
largest drawback to this method is that it requires a special apparatus for increased
pressures (80–90 atm of CO is common). Although this reaction can be used to append a
formyl group onto an alkyl or aryl backbone, it is most useful when the intermediate acyl
radical reacts further in either an inter- or intramolecular sense.
The third method for generation of acyl radicals is the photochemical cleavage of
C–C bonds of ketones, known as the Norrish type I reaction (method c, Scheme 4).
Irradiation of a ketone excites it (n→π*) into the singlet state, which rapidly undergoes
intersystem crossing to the triplet excited state, from which homolytic α-cleavage can
occur.43 The weaker of the two C–C bonds is cleaved, generating the most stable alkyl
radical. The reaction is facilitated by ring strain in the case of cycloalkanones. One
advantage of this reaction is that it cleanly generates acyl radicals for use in spectroscopic
studies.17
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Acyl radicals are considered nucleophilic radicals because they add more
efficiently to electrophilic species. Regardless of the fashion in which they are generated,
acyl radicals can undergo several types of reactions, including decarbonylation,
homolytic substitution, additions to π bonds, and oxidation/reduction chemistry. These
reactions are summarized in Scheme 5, and will be discussed below. However, oxidation
and reduction reactions will not be discussed here because the acyl radical is typically
just an intermediate in the reaction, and this type of reaction is not pertinent to the work
that will be presented in this thesis.
O

–CO

R•

decorbonylation

O

oxidation or reduction
R

R

X–Y
homolytic
substitution

O
or
OH

R

Z
addition

O

O
+ Y•

R

X

R

Z

Scheme 5. Reactions of Acyl Radicals

Decarbonylation is the reversible loss of carbon monoxide from an acyl radical to
form an alkyl radical. The rate of decarbonylation depends on the nature of the alkyl or
aryl group and reflects the stability of the alkyl radical formed; the relative rates17 are
ArCH2C(O)• > R3CC(O)• > R2CHC(O)• > RCH2C(O)• > CH3C(O)• >> ArC(O)•.
Although decarbonylation can be a useful tool for removal of an unnecessary carbonyl
group, more frequently it is an undesired side reaction. For example, Boger and
Mathvink reported44 a series of intramolecular acyl radical addition reactions in which the
yield of cyclized product uniformly decreased as substitution at the α-carbon
incrementally increased (Scheme 6). However, decarbonylation is attenuated at lower
10

temperatures. Consequently, an O2/Et3B system has been developed for radical initiation
at room temperature and lower.45,46 In addition, since this reaction is reversible, simply
running the reaction under a moderate pressure of CO can bias the equilibrium toward the
acyl radical.47
R1
R2
COSePh
1

H
R1
R2

Bu3SnH, AIBN
80 °C

2

25a, R = R = H
25b, R1 = Me, R2 = H
25c, R1 = R2 = Me

H O
26a, 86%
26b, 68%
26c, 49%

Scheme 6. Decarbonylation can Attenuate Yields

A second type of reaction that acyl radicals can undergo is homolytic substitution
(Scheme 5). This reactivity of acyl radicals has been exploited to convert aldehydes
directly into acyl chlorides,48 bromides,49 and iodides,50 most of which were trapped in
situ by alcohols or amines to form the corresponding esters or amides. Perhaps the most
efficient of these transformations is the AIBN-initiated conversion of aldehydes into acyl
bromides using N-bromosuccinimide.49 Acyl radicals can also substitute at sulfur,
selenium, and tellurium atoms, generating acyl sulfides, selenides, and tellurides
respectively.17 However, these reactions are less useful because they require an acyl
radical to form substrates that are most commonly used as acyl radical precursors.
The most synthetically useful reaction of acyl radicals is their addition to π bonds,
most commonly to an alkene.26 Because of their nucleophilic nature, acyl radicals add
more efficiently to electron-poor alkenes such as α,β-unsaturated carbonyl compounds.
(This type of reaction creates a 1,4-dicarbonyl compound, which is complementary to the
formation of 1,5-dicarbonyl compounds by means of the Michael addition of an enolate
in traditional ionic chemistry.) Acyl radicals add to alkenes in both inter- and
11

intramolecular reactions.44 In fact, macrocylization has been performed by
intramolecular addition of acyl radicals to enones and acrylates.51,52 One issue that has
complicated the synthetic applications of acyl radical additions to alkenes is the
occasionally poor exo/endo selectivity. This issue is thoroughly discussed in the review
by Chatgilialoglu et al.17 They conclude that “acyl radical cyclizations are not reversible
on any kinetically significant time scale and that endo mode products can arise both by
Beckwith/Dowd-type rearrangement of exo cyclized radicals or directly from the acyl
radical depending on the substitution patterns employed.” This conclusion is depicted in
Scheme 7. Despite this irregular complication, the addition of acyl radicals to alkenes
has found application in total synthesis endeavors.53
O

O

O
OR

O

Scheme 7. The Exo/Endo Problem

Of particular interest in our case is the ability of acyl radicals to add to π bonds in
a 7-exo fashion. Although there are not many examples of this mode of acyl radical
addition, it is a known process that can proceed in good yield and afford good
diastereoselectivity given the proper arrangement of substituents. To the best of our
knowledge the work presented in this section is a summary of all documented examples
of this type of acyl radical cyclization.
The first examples of acyl radicals undergoing 7-exo-trig cyclizations were
reported by Boger and Mathvink26,44 and are shown in Scheme 8. As with most other
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examples, the acyl radicals were formed from a corresponding selenoester. Conversion
of 27a-b to 28a-b shows the improved efficiency of acyl radical additions to electrondeficient alkenes relative to non-activated alkenes. In fact, the formation of 28a is the
only known example of an acyl radical adding to a non-activated alkene in a 7-exo
fashion.
SePh
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X

O

27a, X = H
27b, X = CO2CH3
COSePh
CO2CH3

X

Bu3SnH, AIBN
C6H6, reflux

28a, X = H, 74%
28b, X = CO2CH3, 92%
Bu3SnH, AIBN
C6H6, reflux
71%

29

O
30

CO2CH3

Scheme 8. 7-Exo Cyclizations of Acyl Radicals (Boger and Mathvink)

Andrew Evans has also contributed significantly to the field of acyl radical
addition reactions. He and his co-workers have performed the 7-exo cyclizations54–57
shown in Scheme 9. The first and second examples demonstrate the intramolecular
addition of acyl radicals to vinylogous sulfonates and carbonates respectively, for the
diastereoselective formation of tetrahydrooxepines. Of note, the major isomer of 32 is
the product derived from a chair-like transition state in which both substituents occupy
pseudo-equatorial positions.
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Scheme 9. 7-Exo Cyclizations of Acyl Radicals (Evans)

Scheme 10 shows an example of a 7-exo cyclization of an acyl radical, in which
Bonjoch and co-workers describe the decarbonylation of α-amino acyl radicals but not of
the corresponding β-amino acyl radicals.58,59 This is the only example of a 7-exo acyl
radical addition forming a bridged bicyclic compound.
O
Bn

N

Bn
H N

SeCH3
(TMS)3SiH, AIBN
C6H6, reflux
71%

CN

H O
CN
38 (α:β = 5:2)

37

Scheme 10. 7-Exo Cyclizations of Acyl Radicals (Bonjoch)

Ryu and co-workers have demonstrated the 7-exo addition of acyl radicals to the
nitrogen atom of imines (Scheme 11), in which the acyl radicals were generated by
carbonylation of vinyl radicals.60,61 The Z-selectivity of 40 was attributed to a weak
electronic interaction between the carbonyl oxygen and the tin atom, whereas the
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contrasting E-selectivity of 41 was attributed to steric repulsion. They were able to
demonstrate this methodology over a broad range of substrates for the preparation of 4- to
9-membered α-methylene lactams.
Bu3SnH or (TMS)3SiH,
AIBN, CO (80–90 atm)

N

O
G

N

C6H6, reflux
40, G = Bu3Sn, 69%, E:Z = 19:81
41, G = (TMS)3Si, 54%, E:Z = 85:15

39

Scheme 11. 7-Exo Cyclizations of Acyl Radicals (Ryu)

1.5 Acyl Radical Cascade Reactions
Acyl radicals have also been employed in radical cascade reactions, in which
multiple C–C bonds and more than one ring are formed in a single chemical
transformation. This class of reactions has been referred to as cascade, domino, or
tandem reactions. McCarroll and Walton have written a review on radical cascades62 in
which they explain the relationship between the acyclic precursors and the complex
polycyclic products. “The structure of the precursor molecule(s) must be carefully
‘programmed’ to enable a complex, scripted, reaction coordinate to be followed,
predictably bringing about a drastic configurational change, and ending in the target
molecular design.” They refer to the precursor molecules as “chemical algorithms”.
They also developed a nomenclature system to describe radical cascade reactions.
According to their system, our proposed cascade would be a C7xC6x process. To the best
of our knowledge this is a novel radical cascade system.
Chatgilialoglu et al. included a section on tandem reactions in their review of acyl
radicals.17 Herein will be presented only a few interesting examples. The first (Scheme
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12) shows one of several radical cascade approaches to the angular triquinane ring
system.41 Treatment of 5,5-disubstituted cyclopentadiene 42 with stannyl radicals
generated an acyl radical which added across an alkene in a 5-exo-trig fashion to generate
the allylic radical 43. A second 5-exo-trig cyclization afforded the diastereomers 44 and
45 along with the prematurely reduced bicyclic compound 46 in a 1:5:2 ratio. Of note,
the “movement” of the radical center in intermediate 43 due to its allylic nature is
formally considered a 1,3-transposition.
SeMe
O

Bu3SnH, AIBN
C6H6, reflux
62%
O
42

43

+
O

+
O

44

O
45

46

Scheme 12. Acyl Radical Cascade (Curran)

Another impressive example of the use of an acyl radical in a cascade cyclization
is the transformation63 of phenyl selenoester 47 into the steroidal tetracyclic ketone 48
(Scheme 13). The initially formed acyl radical undergoes four consecutive 6-endo-trig
cyclizations, each of which is completely diastereoselective. Unfortunately the
propagation step was not, and the D ring was formed as a mixture of methyl epimers.
This example shows the potential of radical cascades for the diastereoselective formation
of polycyclic compounds.
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Bu3SnH, AIBN
C6H6, reflux
78%

O SePh

H
O

47

H

H
48

Scheme 13. Acyl Radical Cascade (Pattenden)

Pattenden has reported another remarkable example of an acyl radical cascade for
the formation of steroid ring systems.64 This cascade proceeds from phenyl selenoester
49 (Scheme 14) via two consecutive 6-endo-trig cyclizations, a cyclopropylcarbinyl ring
opening (formally a 1,4-transposition), a 9-endo-trig macrocyclization, and finally a
transannular 5-exo-trig addition. This cascade gave the unusual cis, anti, cis, anti, cis
diastereomer 50 as the major product.
CO2Me
MeO2C

PhSe

CO2Me
Bu3SnH, AIBN
C6H6, reflux
45%

O

MeO2C
H
O

49

H
H

H
50

Scheme 14. Acyl Radical Cascade (Pattenden)

The last example of note involves a 7-endo-trig/5-exo-dig cascade, which was
favored over the competing initial 6-exo-trig cyclization.65,66 Acyl radical generation
from phenyl selenoester 51 generated the bicyclo[5.3.0]decane ring system of 52 in
modest yield and as a mixture of four diastereomers (Scheme 15). Presumably the 1,3dioxolane prevents the substrate from adopting a conformation favorable for a 6-exo
approach of the acyl radical.
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Scheme 15. Acyl Radical Cascade (Crich)
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CHAPTER 2. SYNTHESIS OF THE RADICAL CASCADE PRECURSOR
In order to explore the proposed novel acyl radical cascade cyclization we began
by developing a synthesis of the model radical cascade precursor. A brief retrosynthetic
analysis of phenyl selenoester 23 is shown in general form in Scheme 1. In the reverse
direction from 23, standard transformations reveal compound 53. The key disconnection
in the retrosynthetic analysis is an alkylation reaction of an appropriately functionalized
ketone (54) with bromide 55 to install the carbon framework of 53. The R-groups in
compounds 54 and 53 must provide functionality that can be converted into alkenes. We
envisioned that bromide 55 could be derived from known1 lactone 56 through the
intermediacy of a differentially protected diol in which each alcohol group is primary.
OP

SePh

O

O

R2
OTBS

R1

23

53
OP

O
2

R

O

+

O

1

R

Br
54

55

56

Scheme 1. Retrosynthetic Approach to Phenyl Selenoester 23

2.1 Synthesis of Bromide 55
In the forward direction, lactone 56 was prepared according to Kim’s method2 and
subjected to basic hydrolysis. Both the alcohol and acid functionalities of the resulting
hydroxy acid were protected with PMB–Cl to give 57 (Scheme 2). It should be noted
that limited attempts to use other protecting groups such as TBS resulted in reformation
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of the lactone, which was a standard byproduct in the bisprotection reaction. LAH
reduction of 57, followed by protection with the appropriate silyl chloride provided a
series of differentially protected diols (58a-c). The PMB group was then removed by
oxidative cleavage using 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) to afford the
parallel set of mono-protected diols 59a-c.
O

O
1. NaOH
O
56

OPMB

2. NaH, PMB-Cl
TBAI, THF
63%
OR

OPMB
58a, R=TBS
58b, R=TBDPS
58c, R=TIPS

OPMB

1. LAH
2. R-Cl, imid.
83-94%

57
DDQ
60–86%

OR
OH
59a, R=TBS
59b, R=TBDPS
59c, R=TIPS

Scheme 2. Synthesis of Mono-Protected Diols

Initially, only mono-tert-butyldimethylsilyl diol 59a was prepared. However,
when it was subjected to a Mitsunobu-type bromination, the result was an approximately
2:1 mixture of bromo alcohol 61 and dibromide 62 (Table 1). A search of the literature
revealed that the Mitsunobu bromination procedure is an efficient method for the direct
conversion of alkyl silyl ethers to alkyl bromides, in which more bulky silyl ethers
require longer reaction times.3 Although the mechanism of this transformation was not
proposed in the cited communication, it can be inferred from the presence of bromo
alcohol 61 in the product mixture that under Mitsunobu conditions the silyl ether is first
cleaved, and that the resulting alcohol is subsequently converted into the bromide.
Accordingly, we next attempted to use this transformation to our advantage by switching
the TBS and PMB protecting groups, which would eliminate a deprotection step.
However, as mentioned above, bisprotection of the hydroxy acid resulting from the
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saponification of 56 with TBS–Cl resulted in reformation of the lactone, even when NaH
was employed as the base.
Consequently, we began to screen the Mitsunobu-type brominations of the more
bulky mono-tert-butyldiphenylsilyl and triisopropylsilyl diols 59b and 59c, hoping that
the increased bulk of the silyl ethers would retard the rate of the undesired bromination.
The reaction with 59b gave an almost 1:1 mixture of the inseparable regioisomeric
bromides 55b and 60b (Table 1), the latter presumably arising from silyl migration.4
When the reaction conditions were applied to mono-TIPS diol 59c some of the desired
product formed and less silyl migration occurred (Table 1), but a significant amount of
TIPS-deprotection was observed, giving an approximately 1:<0.5:1 mixture of
compounds.
Table 1. Bromination of Mono-Protected Diols 59a-c
OR
OH

Conditions A: Ph3P, Br2, CH2Cl2
Conditions B: MsCl, Et3N, LiBr, THF

59a, R=TBS
59b, R=TBDPS
59c, R=TIPS
OR

Br

+

OH

+
OR

Br
55a-c

60a-c

Br
61

Br
62

Substrate

Conditions

Ratio of
55:60:61:62

Combined
Yield

59a
59b
59c
59c
59b

A
A
A
B
B

0:0:2:1
1:1:0:0
1:<0.5:1:0
1:0:0:0
1:0:0:0

94%
63%
71%
93%
77%

59a

B

1:0:0:0

99%
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Based on the above results it was apparent that the Mitsunobu-type bromination
was not going to lead to any synthetically useful results in our case, and that other
reaction conditions should be explored. We next attempted the desired transformation by
means of a one-pot mesylation/bromination. Treatment of 59a-c with MsCl, Et3N, and
LiBr in THF5 afforded the desired bromides 55a-c, with the only detectable byproduct
being the corresponding mesylate, which could be completely converted to the bromide
after extended reaction times (4–6 days). Employing this procedure, bromides 55a-c
were prepared in high yields, often with no need for chromatography (Table 1). A study
of the brominations run in parallel revealed that 59a (TBS ether) reacted the fastest, 59b
(TBDPS ether) was a close second, and 59c (TIPS ether) was significantly slower. Since
the bromination was faster and the TBS group is easier to remove, we chose 55a as the
bromide that would be carried on to further reactions.
The sequence of reactions shown in Scheme 2 and Table 1 was amenable to a
multigram preparation of bromide 55a. The six-step method was used to prepare 6.2 g of
the bromide, with an overall yield of 35% from the known lactone 56, an average yield of
84% per step.

2.2 Alkylations
With bromide 55a in hand we next turned our attention to the key alkylation step
and selection of an appropriate ketone. The appropriate ketone would require
β,γ-unsaturation on each side, or some functionality that could easily be converted into
the desired 1,6-diene. We initially attempted the alkylation with β-keto ester 63 (Scheme
3), which was prepared according to a literature procedure.6 Two sets of conditions were
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applied for this alkylation reaction. Neither of them was successful in delivering the
desired product, and in each case the β-keto ester was consumed. We believe that the
β,γ-enone moiety of 63 was isomerizing to the more stable α,β-enone, followed by
polymerization via Michael addition.
O
MeO2C
63

NaH, 55a, Et2O
OR
NaH, NaI, HMPA, 55a
THF

Recovered Bromide,
Isomerization/Polymerization of β-keto ester?

Scheme 3. Alkylation of β-Keto Ester 63

Since we could find no literature precedent for alkylation of a β-keto ester
containing a β,γ-enone moiety we next attempted the alkylation with β-keto ester 64
(Scheme 4), an analogue of 63 in which the alkene is masked as a protected alcohol
(deprotection, oxidation, and Wittig reactions would unmask the alkene). Again, 64 was
synthesized according to literature procedures.7,8 For this alkylation we employed the
conditions developed by Johnson and co-workers9 in which the enolate is formed in THF
using NaH as the base, the bromide is added, most of the THF is removed in vacuo and
replaced with the more polar solvent acetonitrile, and NaI is added as a nucleophilic
catalyst. The reaction is then heated (60 ºC) for an extended period of time. Following
this procedure, we were able to isolate the desired alkylation product 65 (Scheme 4) in
yields of up to 47%. The remainder of bromide 55a was typically converted into its
iodide and styrene derivatives. However, the yields of the desired product were modest
at best, and they varied significantly (15–47%). In addition, the reactions subsequent to
the alkylation proved problematic, so ultimately we chose another approach to the desired
diene.
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OTBS
O

NaH, 55a, THF
then
NaI, CH3CN, Δ
15–47%

OPMB

EtO2C
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O

65

OPMB

+

iodide and styrene
derivatives of
bromide 55a

CO2Et

Scheme 4. Alkylation of β-Keto Ester 64

After making limited progress on the reactions following the alkylation of 64 we
recognized the possibility of employing a symmetrical ketone in the alkylation step.
Initially we focused on the synthesis and alkylation of a bisprotected β,β'-dihydroxy
ketone. We began by protecting the ketone of diethyl acetone-1,3-dicarboxylate
(DEADC, 66) as the 1,3-dioxolane to give 67 (Scheme 5). Reduction of the esters and
protection of both free alcohols as PMB ethers afforded 68. Acid hydrolysis of the
acetal, which surprisingly also partially cleaved the PMB ethers, gave the symmetrical
ketone 69. When ketone 69 was subjected to low-temperature alkylation conditions
(LDA in THF, –78 ºC) with bromide 55a, and the reaction allowed to warm to room
temperature overnight, 55a was recovered in a near quantitative amount. In addition,
PMB–OH was isolated (62% yield based on two equivalents), and following work-up a
polymeric film formed. Obviously the enolate was undergoing E1cb elimination of the
alkoxide of PMB–OH, and the newly generated enone was subsequently polymerizing.
This is the result that we should have expected based on the substrate.
O
EtO2C

CO2Et

ethylene glycol
cat. TsOH
benzene, Δ
54%

EtO2C

66

O

O

1. LAH, THF
CO2Et

67
O

PMBO

OPMB

68

O

PPTS

O

acetone, Δ
63%

2. NaH, PMBCl, TBAI
45% over 2 steps

PMBO

OPMB

69

Scheme 5. Synthesis of diPMB-Dihydroxy Ketone 69
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Following the unsuccessful alkylation employing a protected β-hydroxy ketone, a
literature search revealed that free β-hydroxy esters have been successfully used in
alkylation reactions.10 Accordingly, reduction of DEADC (66) with NaBH4 gave
β-hydroxy ester 70, with no need for purification. A single attempt at a low-temperature
alkylation (2 eq. LDA) of 70 with bromide 55a resulted in the disappearance of 70 and
near complete conversion of the bromide into the corresponding styrene 71 (Scheme 6).
Presumably the alkoxide of 70 promoted the elimination of bromide 55a rather than its
alkylation.

66

NaBH4
MeOH

1. LDA, THF
–78 oC

OH
EtO2C

CO2Et
70

2. bromide 55a,
HMPA

OTBS
71

Scheme 6. Attempted Alkylation of Free β-Hydroxy Ester 70

Eventually we realized that DEADC (66) itself is a symmetrical β-keto ester, and
has potential to be alkylated with bromide 55a. After a failed attempt at performing this
alkylation using NaOEt as the base in refluxing EtOH (complete conversion of the
bromide into styrene 71), we applied Johnson’s alkylation conditions9 that were
previously successful in the alkylation of β-keto ester 64 (see Scheme 4). We again
found these conditions to be successful (Scheme 7), and were able to isolate compound
72 in a respectable yield of 41%. Upon scaling to 500 mg of the bromide, increasing the
number of equivalents of DEADC to four, adding the bromide after switching solvents,
and running the reaction at a higher concentration, the yield improved to a very satisfying
84%. Apart from improved yields, other advantages of this alkylation include the
commercial availability of DEADC and the possibility of converting both esters of 72
into alkenes simultaneously. We hoped this would simplify the synthesis of phenyl
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selenoester 23. It should be noted that this alkylation reaction was also amenable to
scale-up; when the reaction was performed on 4.7 g of the bromide the yield was
maintained at a healthy 73%.
OTBS

O
CO2Et +
CO2Et

66

Br

55a

OTBS

NaH, THF
then
NaI, CH3CN
60 °C, 6 days
84%

O
CO2Et

72

CO2Et

Scheme 7. DEADC Alkylation

2.3 Synthesis of the Phenyl Selenoester
With the framework of phenyl selenoester 23 in place, functional group
manipulations were to provide the desired radical cascade precursor. We expected that
both esters of 72 could be converted into alkenes simultaneously through the
intermediacy of a dialdehyde. We began by reducing the ketone of 72 with NaBH4. The
alcohol was then protected as a TBS ether, and the esters were both converted into
Weinreb amides11 in good yield to give bis-Weinreb amide 73 (Scheme 8). The
reduction step generated a second stereocenter, and NMR analysis following TBS
protection of the alcohol indicated a 2:1 mixture of the two diastereomers. Based on the
reduction of a similar substrate reported in the literature12 employing nearly identical
conditions, we have tentatively assigned the relative stereochemistry of the major
diastereomer as syn. Although the mixture of diastereomers was carried on, as we
progressed through the remainder of the synthesis the minor diastereomer (the anti
diastereomer) was purified out.
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1. NaBH4, MeOH
2. TBS-OTf, 2,6-lut.
CH2Cl2, 60%

OTBS
O
CO2Et

72

CO2Et

3. MeN(OMe)H•HCl
i-PrMgCl, THF
–10 ºC → rt, 72%

OTBS
OTBS
CON(OMe)Me

73

CON(OMe)Me

Scheme 8. Preparation of Bis-Weinreb Amide 73

Initial attempts to reduce both Weinreb amides of 73 to aldehydes using DIBAL
gave inconsistent mixtures of products that still exhibited some Weinreb amide signals in
the crude NMR. In order to explore this reaction, 80 mg of bis-Weinreb amide 73 was
subjected to DIBAL reduction at –78 ºC, and every two hours a sample was removed,
quenched, and analyzed by NMR. After the first two hours of reaction the NMR showed
one set of Weinreb amide signals and an aldehyde signal corresponding to one hydrogen.
In subsequent NMR’s the relative integration of the aldehyde signal slowly decreased and
the Weinreb amide signals remained unchanged. We concluded that the less hindered
Weinreb amide was being reduced to an alcohol prior to reduction of the more hindered
Weinreb amide to the aldehyde. This is likely due to a coordination between the
tetrahedral aluminum complex of the first reduced Weinreb amide and the unreduced
second Weinreb amide. This complex would prevent another molecule of DIBAL from
coordinating with the more hindered Weinreb amide, a necessary first step for the desired
second reduction to occur. To circumvent this problem we performed the
reduction/Wittig sequence in a stepwise fashion. As shown in Scheme 9, DIBAL
reduction of 73 for only two hours, followed by a Wittig reaction with methyltriphenylphosphonium bromide, afforded alkene 74. At this point any remaining anti diastereomer
was separable. Repeating the procedure installed the requisite 1,6-diene (75). As
evidenced by the modest yields, this four-step sequence has yet to be fully optimized.
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Highly selective cleavage of the primary TBS ether of 75 in the presence of the
secondary TBS ether with (1S)-(+)-(10)-camphorsulfonic acid (CSA) then gave benzyl
alcohol 76.
OTBS

OTBS
OTBS
CON(OMe)Me

73

CON(OMe)Me

1. DIBAL, THF, –78 ºC

OTBS

2. n-BuLi, Ph3PCH3Br
THF, 57%
74

OTBS

1. DIBAL, THF, –78 ºC

OTBS

2. n-BuLi, Ph3PCH3Br
THF, 56%

CSA
CH2Cl2,
MeOH

CON(OMe)Me

OH
OTBS

0 ºC, 87%
75

76

Scheme 9. Double Reduction/Wittig Approach to Diene Formation

The completion of the synthesis of phenyl selenoester 23 was accomplished by
successive Swern and sodium chlorite oxidations, followed by phenylselenation (Scheme
10). As discussed in chapter 1, phenyl selenoesters can be prepared from the appropriate
carboxylic acids or acyl chlorides using a variety of conditions. We initially attempted
the phenylselenation employing Grieco’s conditions13 of N-phenylselenophthalimide and
Bu3P in CH2Cl2 (3a, Scheme 10). Although these conditions did generate phenyl
selenoester 23 in low yield, compound 77, the product of phthalimide substitution, was
the major product. (This type of byproduct was not mentioned in Grieco’s
communication.) The yield of phenyl selenoester 23 was improved to 87% over the last
three steps by switching the source of the phenylseleno group to diphenyl diselenide14
(3b, Scheme 10).
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NaH2PO4,

SePh
O

OTBS

3b. PhSeSePh,
Bu3P, CH2Cl2
87% over 3 steps

Scheme 10. Oxidation and Phenylselenation

syn-23

To summarize, we have successfully developed a synthesis of model phenyl
selenoester syn-23. The synthesis is eighteen steps from known lactone 56 (nineteen
steps from a commercially available compound), and has been achieved in an overall
yield of 4.1%. The highlights of this synthesis include the use of a lactone as a precursor
to a differentially protected diol in which each alcohol is primary, an alkylation of a
phenethyl bromide with suppression of the corresponding facile elimination, and a
stepwise installment of the two alkenes required to model the proposed acyl radical
cascade. This last feature will be beneficial if we have a need to modify one of the
alkenes (for example, replace it with an alkyne). An additional benefit of the synthesis is
the ability to selectively choose the diastereomer. Although we have not yet explored
this, the abundance of protocols for reduction of a ketone would likely provide a way to
selectively prepare the anti diastereomer.
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CHAPTER 3. MODEL ACYL RADICAL CASCADE STUDIES
With an adequate synthesis of phenyl selenoester 23 (Figure 1) developed, we
next began to study the acyl radical cascade cyclization. This reaction, regardless of the
conditions employed, faces several complications. First, when the acyl radical is
generated, the loss of the phenylseleno group reduces the molecular weight by about onethird. Therefore experimentation on small scales is complicated by a significant
reduction in mass. Second, because there are two radical intermediates along the desired
pathway, premature reduction could generate two undesired products (ignoring possible
stereoisomers). Other types of radical reactions such as hydrogen atom transfer could
lead to additional undesired products. Third, if the cascade does proceed as we predict,
two new stereocenters would be generated, allowing for the possible formation of up to
four diastereomers of the desired product (assuming that the starting material is a single
diastereomer to begin with).
SePh
O
H

OTBS

Figure 1. Phenyl Selenoester syn-23

3.1 Conditions for the Acyl Radical Cascade
We expected that the initial 7-exo-trig cyclization would be the slow step of the
intramolecular cascade. Accordingly we began our studies by attempting the cascade
cyclization employing conditions that Boger and Mathvink developed1 for a 7-exo-trig
cyclization similar to our system (see 27a → 28a, Scheme 8, Chapter 1). Their
conditions called for radical initiation by 2,2'-azobisisobutyronitrile (AIBN) at elevated
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temperatures (refluxing benzene), and for chain propagation by Bu3SnH. When we
applied these conditions to the model system a very complex reaction mixture was
obtained, with the only detectable product being the aldehyde corresponding to reduction
of the acyl radical generated from phenyl selenoester 23.
Because the acyl radical was being reduced prematurely, we thought that a poorer
chain propagator such as tris(trimethylsilyl)silane2,3 would increase the lifetime of the
radical intermediates, hopefully allowing for the desired intramolecular reactions to
occur. Consequently we next employed conditions similar to those used by Evans and
co-workers4 for 7-exo-trig acyl radical cyclizations (see Scheme 9, Chapter 1), in which
initiation occurs through the action of O2 on Et3B and (TMS)3SiH is used as the chain
carrier. As mentioned in Chapter 1, these conditions are known to generate radicals at or
below room temperature.5 In our case, these conditions generated the acyl radical of
phenyl selenoester syn-23 at room temperature and promoted the radical cascade as
proposed! This is evidenced by the lack of aldehydic or olefinic protons in the NMR,
which precludes premature reduction or H-transfer reactions. Other modes of cyclization
(for example 8-endo-trig/5-exo-trig) are unlikely based on their slower rates relative to
7-exo-trig cyclizations.1,3 In addition, NMR analysis does not support the formation of
any alternative cascade cyclization products. Thus, the bicyclo[5.4.0]undecane ring
system of compound 24 was successfully installed (Scheme 1) in a very high yield of
93%. The reaction also appears to be highly diastereoselective as we have only been able
to isolate a single diastereomer. To the best of our knowledge, this is the first reported
example of an acyl radical cascade in which the first cyclization is in the 7-exo mode.
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SePh

Et3B, O2
(TMS)3SiH
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OTBS

H OTBS
24

Scheme 1. Acyl Radical Cascade Cyclization of Phenyl Selenoester syn-23

3.2 Stereochemistry of the Acyl Radical Cascade
With the successful acyl radical cascade completed, our next goal was to
determine the relative stereochemistry of the major diastereomer. We propose that the
major diastereomer will be the product in which the most possible groups are in
equatorial or pseudo-equatorial positions in the transition states of each cyclization.
Evans and co-workers have described similar selectivities in 7-exo-trig acyl radical
cyclizations.6,7 According to this model, acyl radical 78 (Scheme 2) would close on the
first alkene in a 7-exo fashion, such that both alkyl substituents occupy pseudo-equatorial
positions in the transition state. This would generate the trans ring fusion of primary
radical 79. The transition state of the second cyclization would also adopt a chair-like
conformation in which the exo methylene group occupies an equatorial position. This
would provide primary radical 80 with the stereochemistry shown. The TBS ether must
occupy an axial position in the transition state between 79 and 80 because of the syn
stereochemistry of 23, and would reinforce the preference for the methylene group to be
in an equatorial position in order to avoid highly energetic 1,3-diaxial interactions. This
prediction leads to 24 with the relative stereochemistry shown in Scheme 2.
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Scheme 2. Proposed Stereochemistry of the Acyl Radical Cascade

To support the proposed relative configuration of all of the stereocenters of 24, we
performed a detailed NMR analysis (1H, 13C, COSY, NOE, NOESY). The first piece of
information supporting our assignment of the stereochemistry of 24 is the coupling of the
α-proton (HA, 24, Figure 2). It is a triplet with a coupling constant of 12.5 Hz, indicating
that it has a trans-axial relationship with two protons (HB and HC). This supports our
prediction of the ring fusion stereochemistry as trans. Next, an NOE on HD (α to the
TBS ether, 24, Figure 2) did not show any through-space coupling with HA. This
supports our original assignment of the acyl radical precursor (23) as syn. If the relative
stereochemistry of HB and HD were anti, then HA and HD would have a 1,3-diaxial
relationship and should exhibit a strong NOE. Another piece of data supporting the
original syn relationship of 23 is that HD appears as a broad singlet, indicating that it is
coupled to multiple protons, all with small coupling constants. This splitting pattern is
more characteristic of an equatorial hydrogen than of an axial hydrogen.8
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Figure 2. Conformations of 24 for NMR Analysis

The relative stereochemistry of the distal methyl group was slightly more
challenging to determine, although the preference for a chair-like transition state for a
6-exo-trig cyclization is widely accepted.9 Ideally, an NOE between HA and HE (24,
Figure 2) would confirm the proposed stereochemistry. Unfortunately, HA and HE are not
completely resolved on a 500 MHz 1H NMR (t, 2.44, J = 12.5 Hz and m, 2.53–2.46
respectively), preventing a conclusive NOE analysis. Consequently, in order to support
the proposed stereochemistry of the methyl group, we must first suppose it to be opposite
of that predicted by the chair-like transition state shown in Scheme 2. If this were the
case, the six-membered ring would likely adopt a boat conformation (see epi-methyl 24,
Figure 2) in order to avoid a 1,3-diaxial interaction between the TBS ether and the methyl
group. Such a conformation should show a very strong NOE between HA and HF (the
flagpole hydrogens), which is not present. This supports our original prediction of the
stereochemistry of 24 as shown in Scheme 2. We are currently attempting to make a
crystalline derivative of 24 to unambiguously confirm our stereochemical prediction.
In conclusion, we have demonstrated the first example of a 7-exo-trig/6-exo-trig
acyl radical cascade reaction. This remarkable transformation forms two new C–C bonds
and generates two stereocenters in a highly regio- and stereoselective manner. This
cascade reaction should be a useful tool for the preparation of the bicyclo[5.4.0]undecane
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ring system, and should have applications in total synthesis, including that of Lyconadin
A as described herein.
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CHAPTER 4. FUTURE WORK AND CONCLUSIONS
4.1 Stereochemical Issues of the Radical Cascade
We have successfully demonstrated that the novel 7-exo-trig/6-exo-trig acyl
radical cascade cyclization can be employed to prepare the bicyclo[5.4.0]undecane ring
system in excellent yield and with a high degree of stereoselectivity. Although we have
predicted the relative stereochemistry of the model acyl radical cascade product (24,
Figure 1) based on chair-like transition states and we have supported that prediction with
NMR data, our immediate goal is to confirm the stereochemistry of 24. We will attempt
to do this by X-ray analysis of a derivative of 24. Both the alcohol (free alcohol or
p-nitrobenzoyl ether) and the ketone (2,4-dinitrophenylhydrazine or a semicarbazone)
could serve as handles for converting 24 into a crystalline derivative1 suitable for X-ray
diffraction techniques, which would unambiguously reveal the relative stereochemistry.
O H

H OTBS

Figure 1. Model Acyl Radical Cascade Product (24)

In addition to proving the stereochemistry of 24, we also need to attempt the acyl
radical cascade reaction on the anti diastereomer of phenyl selenoester 23. Because the
relative stereochemistry of 23 is determined during the ketone reduction step (see Scheme
8, Chapter 2) we should be able to find a reducing agent that would provide the opposite
stereoselectivity to that which we observed using NaBH4. For example, Zn(BH4)2 has
been used to selectively reduce β-keto esters to products corresponding to those that
would lead to anti-phenyl selenoester 23.2 We expect that the anti diastereomer would
more strongly enforce a chair-like transition state in the radical cascade process because
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the TBS ether could occupy an equatorial position. However, the stereoselectivity of the
exo methyl group could be attenuated because the alkene would experience much weaker
steric repulsion with a 1,3-diaxial hydrogen than with a TBS ether (see Scheme 2,
Chapter 3).

4.2 Application of the Model Acyl Radical Cascade to Lyconadin A
The relevance of the model acyl radical cascade that we have accomplished to the
total synthesis of Lyconadin A depends on the degree of stereoselectivity achieved and
the relative stereochemistry of the product. An examination of the stereochemistry of the
model radical cascade product (24, Figure 1) relative to that of the corresponding
intermediate in the proposed synthesis of Lyconadin A (15, Figure 2) reveals that the
α-carbon of cyclohepatanone 24 (C-7, Lyconadin A numbering) is of the wrong relative
stereochemistry. However, because of the high degree of stereoselectivity achieved in
the model we would like to employ an analogous reaction in the total synthesis of the
natural product.
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Figure 2. Stereochemistry Required for the Total Synthesis of Lyconadin A

Because the stereocenter we would need to invert is alpha to a carbonyl, we
envision two methods whose net effect would be to epimerize the desired stereocenter of
24. The simplest method would be kinetic protonation of the enolate derived from 24
(Scheme 1). Although the system in which the ring fusion is trans is certainly the
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thermodynamic product, the axial TBS ether could cause protonation of the enolate to
occur from the opposite face, which would give the cis ring fusion3 corresponding to the
stereochemistry needed in Lyconadin A. The preference for protonation on the bottom
side should be exaggerated at low temperatures and with a bulky proton source such as
tert-butyl alcohol. Alternatively, oxidation to the enone of 24 using either the Saegusa
protocol4 or IBX,5 followed by stereoselective reduction6 could also provide the
necessary relative stereochemistry (Scheme 1). Again, the axial TBS ether should shield
the top face so that the reducing agent preferentially approaches from the bottom face.
O H

O H

1. LDA, THF –78 ºC
2. t-BuOH –78 ºC
H OTBS

H OTBS
epi-Cα 24

24
Saegusa ox.
or IBX O

stereoselective
reduction

O
OR
H OTBS

OTBS
81

82

Scheme 1. Suggested Methods for Epimerization of 24

With the information we have gained about the 7-exo-trig/6-exo-trig acyl radical
cascade cyclization from the model studies, we are now in a position to develop a more
detailed stereoselective approach to Lyconadin A. Our initial proposal is described in
Chapter 1 (see Scheme 2, Chapter 1), and based on our results from the model it need
only be modified as shown in Scheme 2, in which the ketone is replaced with a TBS ether
in a syn relationship to the vinyl group. Again the TBS ether will occupy an axial
position in the transition state, and we can expect a high degree of stereoselectivity in
both cyclizations, providing the Cα epimer of 84. Epimerization according to the results

43

of the reactions shown in Scheme 1 should then afford 84 with the proper relative
stereochemistry. It is of note that the aminomethyl group could reinforce both the chairlike transition state of the 7-exo cyclization (it would occupy an equatorial position) and
the stereoselectivity of the epimerization.
SePh
O

Boc
N
O

1. Et3B, O2
(TMS)3SiH
benzene, rt
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83

H
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Scheme 2. Modified Acyl Radical Cascade Approach to Lyconadin A

4.3 Conclusion
In summary, we have proposed a synthetic route to the alkaloid Lyconadin A, in
which the key step is a 7-exo-trig/6-exo-trig acyl radical cascade cyclization. We have
modeled this key reaction by preparing phenyl selenoester syn-23 and exploring its
behavior in the novel acyl radical cascade. This cascade proceeds in high yield and with
excellent diastereoselectivity to provide the bicyclo[5.4.0]undecane ring system of 24.
Unfortunately, the major diastereomer of the cyclization product contains a trans ring
fusion. Consequently, an epimerization of the α-carbon will be necessary in order to
employ this cascade in the proposed total synthesis of Lyconadin A. Despite this, the
studies we have performed on the model system have provided us with valuable
information applicable to a stereoselective approach to the first total synthesis of
Lyconadin A.
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CHAPTER 5. EXPERIMENTAL AND SPECTROSCOPIC DATA
5.1 General Methods
Tetrahydrofuran, ether, N,N-dimethylformamide, methylene chloride, acetonitrile,
dimethylsulfoxide, diisoproylamine, triethylamine, methanol, and benzene were dried by
passage through a Glass Contour solvent drying system containing cylinders of activated
alumina.1 Flash chromatography was carried out using 60–230 mesh silica gel. 1H NMR
spectra were obtained on either a Varian 300 MHz or a Varian 500 MHz spectrometer as
indicated, with chloroform (7.27 ppm) or tetramethylsilane (0.00 ppm) as internal
reference. Signals are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet),
quin (quintet), dd (doublet of doublets), dt (doublet of triplets), br s (broad singlet), m
(multiplet). Coupling constants are reported in hertz (Hz).

13

C NMR spectra were

obtained on one of two Varian spectrometers operating at 75 or 125 MHz respectively (as
indicated), with chloroform (77.23 ppm) as internal reference. The intensities of 1H–1H
COSY and 1H–1H NOESY correlations are reported as follows: w (weak), m (medium), s
(strong). Infrared spectra were obtained on a Nicolet Avatar 360 FT-IR Spectrometer.
Mass spectral data were obtained using FAB techniques by the Brigham Young
University mass spectrometry facility.

5.2 Experimental Details
O
OPMB
OPMB

4-Methoxybenzyl 2-(2-(4-methoxybenzyloxy)ethyl)benzoate (57). To a
solution of isochromanone (56, 7.88 g, 53.2 mmol) in THF (76 mL) and MeOH (30 mL)
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was added aq NaOH (4 M, 106 mL, 424 mmol) dropwise, and the resulting orange
solution was stirred at rt under N2 for 1.5 h. The reaction was quenched by slow addition
of 6 M HCl until the pH was about 2 (ca. 100 mL) and the solution extracted with EtOAc
(5 × 50 mL). The combined organic extracts were washed with H2O (75 mL), dried
(Na2SO4), and concentrated in vacuo. Azeotropic drying with benzene afforded the
hydroxy acid as a white powder (8.44 g).
To a solution of the crude hydroxy acid in anhydrous THF (200 mL) and
anhydrous DMF (27 mL) was added NaH (60% in mineral oil, 5.34 g, 133.5 mmol), and
gas was evolved. 4-Methoxybenzyl chloride (21.3 mL, 24.6 g, 157 mmol) and
tetrabutylammonium iodide (16.0 g, 43.3 mmol) were added, and the mixture stirred at rt
under N2 for 3.5 h. The reaction was quenched with 1 M HCl (100 mL) and partitioned
into EtOAc (100 mL). The organic phase was collected, the aqueous phase extracted
with EtOAc (4 × 75 mL), and the combined organics were washed with brine (2 × 100
mL), dried (Na2SO4), and concentrated in vacuo. Purification by flash chromatography
(SiO2: 5.5 × 60 cm, 5–15% EtOAc in hexanes gradient elution) yielded 57 (11.41 g, 28.1
mmol, 53% over two steps) as a pale crystalline solid: 1H NMR (CDCl3, 300 MHz) δ
7.88 (d, J = 7.8 Hz, 1H), 7.37–7.17 (m, 7H), 6.87 (d, J = 6.6 Hz, 2H), 6.82 (d, J = 6.6 Hz,
2H), 5.23 (s, 2H), 4.37 (s, 2H), 3.74 (s, 3H), 3.73 (s, 3H), 3.64 (t, J = 6.9 Hz, 2H), 3.28 (t,
J = 6.9 Hz, 2H); 13C NMR (CDCl3, 75 MHz) δ 167.5, 159.7, 159.1, 140.7, 131.9 (3C),
130.8, 130.2 (2C), 130.1 (2C), 129.2, 128.2, 126.3, 114.0 (2C), 113.7 (2C), 72.4, 70.8,
66.5, 55.3, 55.2, 34.9; IR (film) νmax 3028, 2941, 2853, 1715, 1608, 1511, 1251, 1085
cm–1; HRMS (FAB) m/z 429.1685 (MNa+, C25H26O5Na requires 429.1678).
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OR
OPMB
58a, R=TBS
58b, R=TBDPS
58c, R=TIPS

tert-Butyl(2-(2-(4-methoxybenzyloxy)ethyl)benzyloxy)dimethylsilane (58a).
To a solution of 57 (11.13 g, 27.4 mmol) in anhydrous THF (120 mL) was added LAH
(1.0 M in Et2O, 30.0 mL, 30.0 mmol) with evolution of gas. The solution was stirred at rt
under Ar for 3 h and quenched by successive dropwise addition of EtOAc (20 mL) and 1
M HCl (120 mL). The solution was extracted with EtOAc (4 × 75 mL) and the combined
extracts were washed with H2O (150 mL), dried (Na2SO4), and concentrated in vacuo to
give a mixture of benzyl alcohols as a yellow oil (11.36 g), which was carried on crude
because purification was more convenient after the next step.
To a solution of the benzyl alcohols (11.36 g) in anhydrous DMF (200 mL) was
added imidazole (5.60 g, 82.3 mmol) and tert-butyldimethylsilyl chloride (12.73 g, 84.4
mmol) (or the appropriate silyl chloride) and the reaction was stirred at rt under N2 for 23
h. The crude reaction mixture was partitioned into Et2O and H2O (100 mL each). The
organic phase was collected and the aqueous phase was extracted with Et2O (3 × 100
mL). The combined organics were washed with H2O (100 mL), dried (Na2SO4), and
concentrated in vacuo. Purification by flash chromatography (SiO2: 5.5 × 47 cm, 5–8%
Et2O in hexanes gradient elution) afforded 58a (9.96 g, 25.8 mmol, 94%) as a colorless
oil: 1H NMR (CDCl3, 300 MHz) δ 7.44–7.40 (m, 1H), 7.24–7.15 (m, 5H), 6.86 (dd, J =
6.6, 2.1 Hz, 2H), 4.75 (s, 2H), 4.44 (s, 2H), 3.78 (s, 3H), 3.64 (t, J = 7.5 Hz, 2H), 2.92 (t,
J = 7.5 Hz, 2H), 0.93 (s, 9H), 0.08 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 159.4, 139.5,
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136.2, 130.7, 129.9, 129.4 (2C), 127.3, 127.3, 126.6, 114.0 (2C), 72.9, 70.7, 63.3, 55.4,
32.8, 26.2 (3C), 18.6, –5.1 (2C); IR (film) νmax 2940, 2862, 1610, 1508, 1463, 1369,
1248, 1177, 1084, 839, 769 cm–1; HRMS (FAB) m/z 409.2181 (MNa+, C23H34O3SiNa
requires 409.2175).
tert-Butyl(2-(2-(4-methoxybenzyloxy)ethyl)benzyloxy)diphenylsilane (58b).
The two-step procedure described above was applied to prepare 58b (319 mg, 0.625
mmol, 83%) as a colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.71–7.68 (m, 4H), 7.52–
7.49 (m, 1H), 7.42–7.33 (m, 6H), 7.24–7.14 (m, 5H), 6.82 (dd, J = 6.6, 2.4 Hz, 2H), 4.79
(s, 2H), 4.34 (s, 2H), 3.77 (s, 3H), 3.56 (t, J = 7.5 Hz, 2H), 2.83 (t, J = 7.5 Hz, 2H), 1.09
(s, 9H); 13C NMR (CDCl3, 75 MHz) δ 159.3, 139.1, 136.2, 135.8 (4C), 133.7 (2C), 130.7,
129.9 (2C), 129.6, 129.4 (2C), 127.9 (4C), 127.4, 127.3, 126.6, 113.9 (2C), 72.8, 70.6,
63.9, 55.4, 32.7, 27.1 (3C), 19.5; IR (film) νmax 3070, 2956, 2931, 2857, 1612, 1513,
1464, 1427, 1248, 1110, 737 cm–1; HRMS (FAB) m/z 533.2493 (MNa+, C33H38O3SiNa
requires 533.2488).
Triisopropyl(2-(2-(4-methoxybenzyloxy)ethyl)benzyloxy)silane (58c). The
two-step procedure described above was applied to prepare 58c (139.5 mg, 0.325 mmol,
82%) as a colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.51 (d, J = 6.6 Hz, 1H), 7.23–
7.14 (m, 5H), 6.86 (dd, J = 6.6, 2.1 Hz, 2H), 4.84 (s, 2H), 4.44 (s, 2H), 3.78 (s, 3H), 3.64
(t, J = 7.5 Hz, 2H), 2.90 (t, J = 7.5 Hz, 2H), 1.19–1.05 (m, 21H); 13C NMR (CDCl3, 75
MHz) δ 159.3, 139.7, 135.8, 130.7, 129.5, 129.4 (2C), 127.0, 126.8, 126.6, 113.9 (2C),
72.9, 70.6, 63.2, 55.4, 32.7, 18.3 (3C), 12.2 (6C); IR (film) νmax 2943, 2865, 1613, 1513,
1462, 1248, 1089 cm–1; HRMS (FAB) m/z 451.2657 (MNa+, C26H40O3SiNa requires
451.2645).
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OR
OH

59a, R=TBS
59b, R=TBDPS
59c, R=TIPS

2-(2-((tert-Butyldimethylsilyloxy)methyl)phenyl)ethanol (59a). Differentially
protected diol 58a (9.96 g, 25.8 mmol) was dissolved in CH2Cl2 (200 mL) and distilled
H2O (10 mL), and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 6.63 g, 29.2 mmol)
was added. The dark green solution was stirred at rt under N2 for 2.5 h, during which
time the color faded to a pale pink. The reaction was quenched with sat NaHCO3 (150
mL), the organic layer was collected, and the aqueous layer was extracted with CH2Cl2 (2
× 100 mL). The combined organic extracts were washed successively with sat NaHCO3
and brine solution (125 mL each), dried (Na2SO4), and concentrated in vacuo. The
residue was purified by flash chromatography (SiO2: 5.5 × 53 cm, 0.25–1.0% MeOH in
CH2Cl2 gradient elution) to afford pure mono-TBS diol 59a (5.35 g, 20.1 mmol, 78%) as
a colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.37–7.34 (m, 1H), 7.25–7.17 (m, 3H),
4.74 (s, 2H), 3.81 (dt, J = 6.6, 5.7 Hz, 2H), 2.89 (t, J = 6.6 Hz, 2H), 2.52 (t, J = 5.7 Hz,
1H), 0.94 (s, 9H), 0.12 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 139.1, 137.0, 130.0, 128.3,
127.9, 126.7, 63.7, 63.4, 35.5, 26.1 (3C), 18.6, −5.1 (2C); IR (film) νmax 3360 (br), 3065,
3026, 2941, 2873, 1464, 1383, 1253, 1064, 844, 769 cm–1; HRMS (FAB) m/z 289.1613
(MNa+, C15H26O2SiNa requires 289.1600).
2-(2-((tert-Butyldiphenylsilyloxy)methyl)phenyl)ethanol (59b). The above
procedure was applied to 58b (267 mg, 0.52 mmol, reagents and solvents scaled
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appropriately) to yield the title compound (172 mg, 0.44 mmol, 84%) as a colorless oil:
1

H NMR (CDCl3, 300 MHz) δ 7.73–7.69 (m, 4H), 7.45–7.34 (m, 7H), 7.24–7.16 (m, 3H),

4.76 (s, 2H), 3.73 (t, J = 6.6 Hz, 2H), 2.80 (t, J = 6.6 Hz, 2H), 1.82 (br s, 1H), 1.08 (s,
9H); 13C NMR (CDCl3, 75 MHz) δ 138.9, 136.4, 135.8 (4C), 133.5 (2C), 130.0 (2C),
129.9, 128.2, 128.0 (4C), 127.7, 126.8, 64.1, 63.2, 35.5, 27.0 (3C), 19.4; IR (film) νmax
3372 (br), 3070, 2932, 2857, 1470, 1427, 1112, 1076, 823, 741, 703 cm–1; HRMS (FAB)
m/z 413.1906 (MNa+, C25H30O2SiNa requires 413.1913).
2-(2-((Triisopropylsilyloxy)methyl)phenyl)ethanol (59c). The above procedure
was applied to 58c (140 mg, 0.33 mmol, reagents and solvents scaled appropriately) to
yield the title compound (63 mg, 0.20 mmol, 62%) as a colorless oil: 1H NMR (CDCl3,
300 MHz) δ 7.46–7.43 (m, 1H), 7.26–7.18 (m, 3H), 4.83 (s, 2H), 3.85 (t, J = 6.3 Hz, 2H),
2.90 (t, J = 6.3 Hz, 2H), 2.17 (br s, 1H), 1.25–1.07 (m, 21H); 13C NMR (CDCl3, 75 MHz)
δ 139.4, 136.5, 129.8, 128.1, 127.8, 126.8, 63.8, 63.4, 35.5, 18.2 (6C), 12.3 (3C); IR
(film) νmax 3350, 2943, 2866, 1463, 1383, 1122, 1065, 882, 682 cm–1; HRMS (FAB) m/z
309.2260 (MH+, C18H33O2Si requires 309.2249).
OR
Br

55a, R=TBS
55b, R=TBDPS
55c, R=TIPS

(2-(2-Bromoethyl)benzyloxy)(tert-butyl)dimethylsilane (55a). LiBr (17.6 g,
203 mmol) was thoroughly flame dried under reduced pressure, cooled, and suspended in
anhydrous THF (190 mL). Alcohol 59a (5.35 g, 20.1 mmol) in anhydrous THF (10 mL)
was added, followed by Et3N (7.0 mL, 5.08 g, 50.2 mmol) and methanesulfonyl chloride
(3.4 mL, 5.03 g, 43.9 mmol). The solution was stirred at rt under N2 for 6 days,
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quenched with H2O (150 mL), and extracted with Et2O (4 × 75 mL). The combined
extracts were washed with H2O (100 mL), dried (Na2SO4), and concentrated in vacuo to
give 55a (6.17 g, 18.7 mmol, 93%) as a yellow oil. The crude material typically needed
no purification, although an analytical sample could be purified by flash chromatography
(SiO2: 1.4 × 22 cm; 5% Et2O in hexanes). 1H NMR (CDCl3, 300 MHz) δ 7.38–7.35 (m,
1H), 7.25–7.16 (m, 3H), 4.73 (s, 2H), 3.56 (t, J = 8.1 Hz, 2H), 3.19 (t, J = 8.1 Hz, 2H),
0.94 (s, 9H), 0.11 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 139.1, 137.1, 129.8, 128.5,
127.9, 127.3, 63.8, 36.4, 32.5, 26.2 (3C), 18.6, –5.0 (2C); IR (film) νmax 3023, 2942,
2869, 1463, 1384, 1254, 1071, 843, 770 cm–1; HRMS (FAB) m/z 351.0763 (MNa+,
C15H25OBrSiNa requires 351.0756).
(2-(2-Bromoethyl)benzyloxy)(tert-butyl)diphenylsilane (55b). The above
procedure was applied to 59b (82 mg, 0.21 mmol, reagents and solvents scaled
appropriately). The crude product was purified by flash chromatography (SiO2: 1.5 ×
13.5 cm; 1:10 Et2O in hexanes) to yield the pure title compound (73 mg, 0.16 mmol,
77%) as a white, amorphous solid: 1H NMR (CDCl3, 300 MHz) δ 7.72–7.68 (m, 4H),
7.44–7.36 (m, 7H), 7.27–7.23 (m, 2H), 7.20–7.16 (m, 1H), 4.73 (s, 2H), 3.50 (t, J = 8.1
Hz, 2H), 3.13 (t, J = 8.1 Hz, 2H), 1.08 (s, 9H); 13C NMR (CDCl3, 75 MHz) δ 138.8,
136.9, 135.9 (4C), 133.5 (2C), 130.0 (2C), 129.7, 128.5, 128.0 (4C), 127.8, 127.3, 64.2,
36.2, 32.4, 27.1 (3C), 19.5; IR (film) νmax 3070, 2958, 2931, 2857, 1471, 1428, 1110,
1068, 738, 704 cm–1; HRMS (FAB) m/z 475.1068 (MNa+, C25H29OBrSiNa requires
475.1069).
(2-(2-Bromoethyl)benzyloxy)triisopropylsilane (55c). The above procedure
was applied to 59c (59 mg, 0.19 mmol, reagents and solvents scaled appropriately) to

52

yield the pure title compound (66 mg, 0.18 mmol, 93%) without need for purification, as
a yellow oil: 1H NMR (CDCl3, 300 MHz) δ 7.46–7.43 (m, 1H), 7.27–7.17 (m, 3H), 4.82
(s, 2H), 3.58 (t, J = 7.8 Hz, 2H), 3.20 (t, J = 7.8 Hz, 2H), 1.25–1.02 (m, 21H); 13C NMR
(CDCl3, 75 MHz) δ 139.4, 136.8, 129.6, 128.1, 127.7, 127.3, 63.8, 36.3, 32.5, 18.3 (6C),
12.3 (3C); IR (film) νmax 2943, 2866, 1462, 1108, 1065, 883, 806, 736, 683, 648 cm–1;
HRMS (FAB) m/z not available (MNa+, C18H31OBrSiNa requires 393.1225).
OTBS
O

OPMB

CO2Et

Ethyl 2-(2-((tert-butyldimethylsilyloxy)methyl)phenethyl)-5-(4methoxybenzyloxy)-3-oxopentanoate (65). To a suspension of NaH (60% dispersion in
mineral oil, 12 mg, 0.31 mmol) in anhydrous THF (0.2 mL) was added β-keto ester 64
(85 mg, 0.30 mmol) dropwise in anhydrous THF (0.2 mL), with violent evolution of gas.
Bromide 55a (53 mg, 0.16 mmol) in anhydrous THF (0.2 mL) was then added, and most
of the solvent was removed in vacuo and replaced with a solution of NaI (12 mg, 0.08
mmol) in anhydrous acetonitrile (0.50 mL). The reaction mixture was then heated to
60 ºC and stirred under Ar for 29 h, cooled, diluted with Et2O (1.0 mL), and quenched
with 1 M HCl (0.5 mL). The organic phase was collected, and the aqueous phase was
extracted with Et2O (1.0 mL). The combined organic phases were washed with H2O
(1.0 mL), dried (Na2SO4), and concentrated in vacuo. The residue was purified by flash
chromatography (SiO2: 2.5 × 25 cm; 10–11% EtOAc in hexanes gradient elution) to give
a 3:1 mixture of the iodo and styrene derivatives of bromide 55a (30 mg, 0.065 mmol
iodide, .022 mmol styrene) and the title compound (40 mg, 0.076 mmol, 47%, 78% based
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on recovered iodide) in equilibrium with its enol tautomer, as a yellow oil: 1H NMR
(CDCl3, 300 MHz) δ 7.43–7.40 (m, 1H), 7.24–7.09 (m, 5H), 6.85 (d, J = 8.7 Hz, 2H),
4.73 (s, 2H), 4.41 (s, 2H), 4.16 (q, J = 6.9 Hz, 2H), 3.78 (s, 3H), 3.70 (t, J = 6.3 Hz, 2H),
3.53 (t, J = 7.2 Hz, 1H), 2.82–2.76 (m, 2H), 2.62–2.56 (m, 2 H), 2.13 (q, J = 7.8 Hz, 2H),
1.25 (t, J = 6.9 Hz, 3H), 0.93 (s, 9H), 0.10 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 203.5,
169.6, 159.4, 139.1, 138.2, 130.3, 129.5 (2C), 129.2, 127.5, 127.4, 126.5, 113.9 (2C),
73.1, 64.9, 63.0, 61.6, 59.2, 55.4, 42.2, 29.9, 28.9, 26.1 (3C), 18.5, 14.3, –5.1 (2C); IR
(film) not collected; HRMS (FAB) m/z 551.2800 (MNa+, C30H44O6SiNa requires
551.2805).

EtO2C

O

O

CO2Et

Diethyl 2,2'-(1,3-dioxolane-2,2-diyl)diacetate (67). In a 3-neck round bottom
flask, p-toluenesulfonic acid monohydrate (1.08 g, 5.7 mmol) was dissolved in benzene
(115 mL), and ethylene glycol (2.3 mL, 41.2 mmol) was added. The round bottom flask
was equipped with a Dean–Stark apparatus, and the mixture was refluxed for 1 h.
Diethyl acetone-1,3-dicarboxylate (DEADC, 66, 5.0 mL, 5.6 g, 27.5 mmol) was added
and the reaction refluxed for 6 h, cooled to rt, quenched with sat NaHCO3 (50 mL) and
stirred for 15 min. The organic phase was collected, and the aqueous phase extracted
with EtOAc (4 × 50 mL). The combined organics were washed with sat NaHCO3 and
brine solution (50 mL each), dried (Na2SO4), and concentrated in vacuo. The residue was
purified by flash chromatography (SiO2: 5.5 × 63 cm; 10–25% EtOAc in hexanes
gradient elution) to give 1,3-dioxolane 67 (3.65 g, 14.8 mmol, 54%) as a yellow oil: 1H
NMR (CDCl3, 300 MHz) δ 4.16 (q, J = 6.6 Hz, 4H), 4.03 (s, 4H), 2.94 (s, 4H), 1.27 (t,
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J = 6.6 Hz, 6H); 13C NMR (CDCl3, 75 MHz) δ 169.4 (2C), 107.0, 65.3 (2C), 60.7 (2C),
42.4 (2C), 14.3 (2C); IR (film) νmax 2978, 2904, 1736, 1325–1112, 1036, 736 cm–1;
HRMS (FAB) m/z 269.0984 (MNa+, C11H18O6Na requires 269.1001).
O

O

PMBO

OPMB

2,2-Bis(2-(4-methoxybenzyloxy)ethyl)-1,3-dioxolane (68). To a solution of 67
(346 mg, 1.40 mmol) in anhydrous THF (14 mL) was added LAH (1.0 M in THF, 2.1
mL, 2.1 mmol) dropwise with evolution of gas. The slurry was stirred at rt under N2
overnight then quenched by successive dropwise addition of H2O (80 μL) with violent
evolution of gas, 15% aq NaOH (80 μL), and H2O (240 μL). The slurry was dried
(Na2SO4), filtered, and concentrated in vacuo.
To a solution of the crude diol (214 mg) in anhydrous DMF (5.6 mL) was added
NaH (60% dispersion in mineral oil, 166 mg, 4.15 mmol) with evolution of gas. The
solution was stirred under Ar at rt for 50 min, after which p-methoxybenzyl chloride (575
μL, 664 mg, 4.24 mmol) was added dropwise, followed by tetrabutylammonium iodide
(208 mg, 0.56 mmol). The resulting mixture was stirred under Ar at rt for 24 h, then at
70 ºC for 17 h. TLC analysis indicated incomplete conversion, so more NaH (60%
dispersion in mineral oil, 175 mg, 4.38 mmol) and p-methoxybenzyl chloride (400 μL,
462 mg, 2.95 mmol) were added, and the reaction stirred under Ar at 70 ºC for an
additional 23 h. The reaction was cooled to 0 ºC, quenched with 1 M HCl (10 mL), and
extracted with EtOAc (4 × 5 mL). The combined organic extracts were washed with
brine (15 mL), dried (Na2SO4), and concentrated in vacuo. The residue was purified by
flash chromatography (SiO2: 3.2 × 41 cm; 10–25% acetone in hexanes gradient elution)
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to give the mono-protected diol (145 mg, 0.51 mmol, 37% over 2 steps) and the title
compound (133 mg, 0.33 mmol, 24% over 2 steps, 37% based on recovered monoprotected diol) as a yellow oil: 1H NMR (CDCl3, 300 MHz) δ 7.24 (d, J = 8.7 Hz, 4H),
6.86 (d, J = 8.7 Hz, 4H), 4.40 (s, 4H), 3.90 (s, 4H), 3.79 (s, 6H), 3.55 (t, J = 7.2 Hz, 4H),
1.98 (t, J = 7.2 Hz, 4H); 13C NMR (CDCl3, 75 MHz) δ 159.3 (2C), 130.8 (2C), 129.5
(4C), 114.0 (4C), 109.7, 72.9 (2C), 66.1 (2C), 65.0 (2C), 55.4 (2C), 37.6 (2C); IR (film)
νmax 2945, 2878, 1726, 1610, 1511, 1460, 1367, 1247, 1169, 1090, 914 cm–1; HRMS
(FAB) m/z not collected (MNa+, C23H30O6Na requires 425.1940).

O
PMBO

OPMB

1,5-Bis(4-methoxybenzyloxy)pentan-3-one (69). To a solution of 68 (133 mg,
0.33 mmol) in acetone (6 mL) and H2O (0.30 mL) was added pyridinium
p-toluenesulfonate (36 mg, 0.14 mmol). The mixture was refluxed for 19 h, cooled,
poured into EtOAc (7 mL), washed with sat NaHCO3 (2 × 5 mL) and brine (5 mL), dried
(Na2SO4), and concentrated in vacuo. The residue was purified by flash chromatography
(SiO2: 2.5 × 30 cm; 10–12% acetone in hexanes gradient elution) to give 69 (78 mg, 0.21
mmol, 63%), contaminated with a trace of PMB-OH. 1H NMR (CDCl3, 300 MHz) δ 7.23
(d, J = 8.7 Hz, 4H), 6.86 (d, J = 8.7 Hz, 4H), 4.43 (s, 4H), 3.80 (s, 6H), 3.71 (t, J = 6.3
Hz, 4H), 2.72 (t, J = 6.3 Hz, 4H); 13C NMR (CDCl3, 75 MHz) δ 207.8, 159.5 (2C), 130.5
(2C), 129.6 (4C), 114.0 (4C), 73.1 (2C), 65.1 (2C), 55.5 (2C), 43.7 (2C); IR (film) νmax
not collected cm–1; HRMS (FAB) m/z not collected (MNa+, C21H26O5Na requires
381.1678).
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OTBS
O
CO2Et
CO2Et

Diethyl 2-(2-((tert-butyldimethylsilyloxy)methyl)phenethyl)-3oxopentanedioate (72). To a suspension of NaH (60% dispersion in mineral oil, 257
mg, 6.42 mmol) in anhydrous THF (10 mL) at 0 ºC under Ar was added diethyl acetone1,3-dicarboxylate (DEADC, 66, 1.16 mL, 1.29 g, 6.39 mmol) dropwise, with rapid
evolution of gas. The mixture was stirred at 0 ºC for 10 min, bromide 55a (450 μL, 513
mg, 1.56 mmol) was added, and most of the THF was removed in vacuo. The sticky
orange residue was dissolved in anhydrous acetonitrile (5.0 mL), NaI (118 mg, 0.79
mmol) was added, and the mixture heated at 60 ºC under Ar for 6.75 days, after which
most of the solvent had evaporated. The residue was cooled to rt, diluted with EtOAc (7
mL) and quenched with 1 M HCl (6 mL). The organic phase was collected and the
aqueous phase extracted with EtOAc (3 × 6 mL). The combined organic phases were
washed with brine (10 mL), dried (Na2SO4), and concentrated in vacuo. The residue was
purified by flash chromatography (SiO2: 3.2 × 37 cm; 10% EtOAc in hexanes) to give the
title compound (590 mg, 1.31 mmol, 84%) in equilibrium with multiple enol tautomers,
as a yellow oil: 1H NMR (CDCl3, 300 MHz) δ 7.44–7.41 (m, 1H), 7.24–7.18 (m, 2H),
7.15–7.12 (m, 1H), 4.74 (s, 2H), 4.26–4.15 (m, 4H), 3.68 (t, J = 7.2 Hz, 1H), 3.60 (d, J =
15.9 Hz, 1H), 3.55 (d, J = 15.9 Hz, 1H), 2.65–2.60 (m, 2H), 2.20–2.12 (m, 2H), 1.31–
1.24 (m, 6H), 0.94 (s, 9H), 0.10 (s, 6H); 13C NMR (CDCl3, 75 MHz) δ 197.5, 169.1,
166.8, 139.1, 138.0, 129.2, 127.6, 127.4, 126.6, 63.0, 61.9, 61.7, 58.7, 48.3, 29.9, 28.9,
26.1 (3C), 18.6, 14.2 (2C), –5.1 (2C); IR (film) νmax 2934, 2858, 1741, 1650, 1464, 1370,
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1317, 1251, 1077, 842, 776 cm–1; HRMS (FAB) m/z 473.2342 (MNa+, C24H38O6SiNa
requires 473.2335).
OTBS
OTBS
CON(OMe)Me
CON(OMe)Me

syn-3-(tert-Butyldimethylsilyloxy)-2-(2-((tert-butyldimethylsilyloxy)methyl)phenethyl)-N1,N5-dimethoxy-N1,N5-dimethylpentanediamide (73). To a solution of
ketoester 72 (163 mg, 0.36 mmol) in MeOH (3.5 mL) at 0 ºC was added NaBH4 (30 mg,
0.78 mmol) with some gas evolution. The solution was stirred under N2 at 0 ºC for 15
min, quenched with sat NH4Cl (3 mL), and extracted with CH2Cl2 (4 × 3 mL). The
combined extracts were dried (Na2SO4), and concentrated in vacuo.
To a solution of the crude alcohol (176 mg) in anhydrous CH2Cl2 (1.8 mL) at 0 ºC
under Ar was added 2,6-lutidine (130 μL, 120 mg, 1.12 mmol) and 5 min later tertbutyldimethylsilyl trifluoromethanesulfonate (166 μL, 191 mg, 0.72 mmol). The reaction
was stirred under Ar and allowed to warm to room temperature over 43 h, then poured
into sat NaHCO3 (2 mL). The organic phase was collected and the aqueous phase
extracted with CH2Cl2 (3 × 2 mL). The combined organic extracts were dried (Na2SO4)
and concentrated in vacuo, then purified by flash chromatography (SiO2: 2.1 × 19 cm, 5%
EtOAc in hexanes) to afford the diester analogue of 73 (122 mg, 0.22 mmol, 60%, ca. 2:1
mixture of diastereomers) as a yellow oil: 1H NMR (CDCl3, 300 MHz) δ 7.46–7.41 (m,
1H), 7.23–7.16 (m, 2H), 7.13–7.10 (m, 1H), 4.75 and 4.74 (2s, 2H), 4.45–4.36 (m, 1H),
4.21–4.06 (m, 4H), 2.70–2.60 (m, 2H), 2.57–2.41 (m, 3H), 1.98–1.72 (m, 2H), 1.30 (t,
J = 7.2 Hz, 3H), 1.23 (t, J = 7.2 Hz, 3H), 0.94 (s, 9H), 0.84 (s, 9H), 0.10 (s, 6H), 0.06 and
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0.04 (2s, 3H), 0.03 and 0.01 (2s, 3H); 13C NMR (CDCl3, 75 MHz) δ 173.6 and 173.5,
171.8 and 171.6, 139.0 and 138.9, 138.7 and 138.6, 129.1 and 129.0, 127.3 and 127.3,
127.2 and 127.1, 126.3, 70.8 and 70.3, 63.0 and 62.8, 60. 6 and 60.6, 52.2 and 51.7, 40.0
and 39.7, 30.6 and 30.5, 29.4, 27.9, 26.1 (3C), 25.8 (3C), 18.5, 18.1 and 18.1, 14.5, 14.3,
–4.6 and –4.7, –4.8, –5.1 (2C); IR (film) νmax 2934, 2859, 1735, 1465, 1378, 1254, 1182,
1083, 838, 777 cm–1; HRMS (FAB) m/z 589.3365 (MNa+, C30H54O6Si2Na requires
589.3357).
To a stirred suspension of MeNH(OMe)•HCl (106 mg, 1.09 mmol) in anhydrous
THF (2.0 mL) at –10 ºC (ice/acetone bath) under Ar was added i-PrMgCl (2.0 M in THF,
1.1 mL, 2.2 mmol) dropwise with bubbling. After stirring for several min at –10 ºC, the
diester described above (244 mg, 0.43 mmol) in anhydrous THF (0.8 mL + 0.4 mL rinse)
was added, and the mixture was stirred under Ar and allowed to warm to rt for 26 hours,
then quenched with sat NH4Cl (5 mL) and extracted with CH2Cl2 (4 × 5 mL). The
combined extracts were dried (Na2SO4) and concentrated in vacuo. The residue was
purified by flash chromatography (SiO2: 2.4 × 23 cm, 2% MeOH in CH2Cl2) to afford
bis-Weinreb amide 73 (184 mg, 0.308 mmol, 72%, mixture of diastereomers possibly
including E/Z Weinreb amides) as an orange residue: 1H NMR (CDCl3, 300 MHz) δ
7.47–7.42 (m, 1H), 7.22–7.16 (m, 3H), 4.76 (s, 1H), 4.75 (s, 1H), 4.62–4.53 (m, 1H),
3.68 (s, 3H), 3.64 (s, 3H), 3.21 (s, 3H), 3.14–3.05 (m, 1H), 3.13 (s, 3H), 2.74–2.52 (m,
2H), 2.52–2.37 (m, 2H), 2.08–1.88 (m, 2H), 0.94 (s, 9H), 0.85 (s, 9H), 0.10 (s, 6H), 0.06
(s, 3H), 0.02 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 173.7, 172.6, 139.1, 139.0, 129.2,
127.1, 127.0, 126.2, 68.8, 62.7, 61.5, 61.4, 48.3 (2C), 35.6 (2C), 30.6 (2C), 26.1 (3C),
25.9 (3C), 18.6, 18.1, –4.8 (2C), –5.1 (2C); IR (film) νmax 2935, 2893, 2858, 1663, 1464,
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1386, 1254, 1077, 839 cm–1; HRMS (FAB) m/z 619.3579 (MNa+, C30H56O6N2Si2Na
requires 619.3575).
OTBS
OTBS

CON(OMe)Me

syn-3-(tert-Butyldimethylsilyloxy)-2-(2-((tert-butyldimethylsilyloxy)methyl)
phenethyl)-N-methoxy-N-methylhex-5-enamide (74). To a solution of bis-Weinreb
amide syn-73 (184 mg, 0.31 mmol) in anhydrous THF (1.8 mL) under Ar at –78 ºC was
added DIBAL (1.0 M in THF, 1.23 mL, 1.23 mmol) dropwise, and the solution was
stirred at –78 ºC under Ar for 2.0 h then quenched by addition of sat aq potassium sodium
tartrate (5.0 mL). The quenched mixture was allowed to warm to rt and stirred
vigorously at rt for 1.0 h, then extracted with CH2Cl2 (4 × 4 mL). The combined extracts
were washed with brine (5 mL), dried (Na2SO4), filtered, and concentrated in vacuo to
give the crude monoaldehyde (192 mg).
To a suspension of methyltriphenylphosphonium bromide (359 mg, 1.01 mmol) in
anhydrous THF (2.0 mL) under Ar was added n-BuLi (1.6 M in hexanes, 0.54 mL, 0.86
mmol) dropwise, and the yellow solution was stirred at rt for 10 min then cooled to
–78 ºC. The crude monoaldehyde (192 mg) in anhydrous THF (0.4 mL + 2 × 0.3 mL
rinses) was then added dropwise, and the solution was stirred under Ar and allowed to
warm from –78 ºC to rt over 18.5 h, then quenched with sat aq NH4Cl (3 mL). The
mixture was then extracted with EtOAc (4 × 3 mL), and the combined extracts were
washed with brine (7 mL), dried (Na2SO4), and concentrated in vacuo. The residue was
purified by flash chromatography (SiO2: 2.4 × 22 cm, 0.5% MeOH in CH2Cl2) to afford
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Weinreb amide syn-74 (95 mg, 0.18 mmol, 57% over two steps) as a yellow oil: 1H NMR
(CDCl3, 300 MHz) δ 7.43–7.40 (m, 1H), 7.22–7.11 (m, 3H), 5.97–5.82 (m, 1H), 5.10–
5.01 (m, 2H), 4.74 (d, J = 13.2 Hz, 1H), 4.69 (d, J = 13.2 Hz, 1H), 4.01 (quin, J = 4.2 Hz,
1H), 3.69 (s, 3H), 3.23–3.12 (m, 1H), 3.20 (s, 3H), 2.49 (t, J = 8.1 Hz, 2H), 2.39–2.30 (m,
1H), 2.28–2.16 (m, 1H), 1.91–1.78 (m, 1H), 1.75–1.63 (m, 1H), 0.94 (s, 9H), 0.86 (s,
9H), 0.09 (s, 6H), 0.05 (s, 3H), 0.00 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 175.2, 139.1,
138.9, 134.4, 129.0, 127.2, 127.2, 126.2, 117.5, 72.6, 62.8, 61.4, 46.5, 38.4, 30.0, 29.0,
26.2 (3C), 26.0 (3C), 18.6, 18.2, –4.6, –4.6, –5.1 (2C); IR (film) νmax 2933, 2858, 1661,
1465, 1254, 1075, 839, 776 cm–1; HRMS (FAB) m/z 558.3409 (MNa+, C29H53O4NSi2Na
requires 558.3410).
OTBS
OTBS

syn-4-(tert-Butyldimethylsilyloxy)-3-(2-((tert-butyldimethylsilyloxy)methyl)
phenethyl)-1,6-heptadiene (75). To a solution of Weinreb amide syn-74 (131 mg, 0.24
mmol) in anhydrous THF (1.3 mL) under Ar at –78 ºC was added DIBAL (1.0 M in THF,
1.22 mL, 1.22 mmol) dropwise, and the solution was stirred at –78 ºC under Ar for 6 h
then poured into a stirred solution of sat aq potassium sodium tartrate (5.0 mL). The
quenched mixture was stirred vigorously at rt for 2.5 h, then diluted with H2O (2.0 mL)
and extracted with CH2Cl2 (4 × 4 mL). The combined extracts were dried (Na2SO4),
filtered, and concentrated in vacuo to give the crude aldehyde, which was combined with
another portion of the identical aldehyde (43 mg, 0.09 mmol).
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To a suspension of methyltriphenylphosphonium bromide (523 mg, 1.55 mmol) in
anhydrous THF (1.4 mL) under Ar was added n-BuLi (1.4 M in hexanes, 1.0 mL, 1.4
mmol) dropwise. The red solution was stirred at rt for 10 min then cooled to –78 ºC, then
added dropwise via syringe to a solution of the mixture of aldehydes (149 mg) in
anhydrous THF (1.0 mL) also at –78 ºC. The solution was stirred under Ar and allowed
to warm from –78 ºC to rt over 18 h, then poured into sat aq NH4Cl (5 mL). The mixture
was then extracted with EtOAc (4 × 3 mL), and the combined extracts were dried
(Na2SO4), and concentrated in vacuo. The crude product was purified by flash
chromatography (SiO2: 2.4 × 20 cm, 2% Et2O in hexanes) to afford diene syn-75 (90 mg,
0.19 mmol, 58% over two steps) as a colorless oil: 1H NMR (CDCl3, 300 MHz) δ 7.45–
7.40 (m, 1H), 7.23–7.10 (m, 3H), 5.81–5.67 (m, 2H), 5.17 (dd, J = 10.2, 1.8 Hz, 1H),
5.11–4.98 (m, 3H), 4.72 (s, 2H), 3.65 (dt, J = 6.3, 3.0 Hz, 1H), 2.69–2.59 (m, 1H), 2.47–
2.37 (m, 1H), 2.29–2.10 (m, 3H), 1.81–1.69 (m, 1H), 1.66–1.51 (m, 1H), 0.94 (s, 9H),
0.88 (s, 9H), 0.10 (s, 6H), 0.03 (s, 3H), 0.01 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 139.8,
139.0, 138.9, 135.8, 128.9, 127.2, 127.1, 126.0, 117.4, 117.0, 75.5, 63.0, 49.7, 39.5, 31.7,
30.3, 26.2 (3C), 26.1 (3C), 18.7, 18.3, –3.9, –4.2, –5.0 (2C); IR (film) νmax 3074, 2955,
2929, 2857, 1472, 1255, 1077, 912, 837, 775 cm–1; HRMS (FAB) m/z 497.3249 (MNa+,
C28H50O2Si2Na requires 497.3247).
OH
OTBS

(2-(syn-4-(tert-Butyldimethylsilyloxy)-3-vinylhept-6-enyl)phenyl)methanol
(76). To a solution of diene 75 (87 mg, 0.18 mmol) in CH2Cl2 (1.9 mL) at 0 ºC under Ar
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was added a solution of (1S)-(+)-(10)-camphorsulfonic acid (9.3 mg, 0.04 mmol) in
MeOH (1.9 mL). The mixture was stirred at 0 ºC under Ar for 1 h and 40 min, then
poured into sat aq NaHCO3 (3 mL) and diluted with CH2Cl2 and H2O (1 mL each). The
organic phase was collected and the aqueous phase extracted with CH2Cl2 (3 × 3 mL).
The combined organics were dried (Na2SO4) and concentrated in vacuo, then purified by
flash chromatography (SiO2: 1.5 × 16.5 cm, 7% EtOAc in hexanes) to afford benzyl
alcohol 76 (57 mg, 0.16 mmol, 87%) as a yellow oil: 1H NMR (CDCl3, 300 MHz) δ
7.39–7.34 (m, 1H), 7.26–7.15 (m, 3H), 5.81–5.67 (m, 2H), 5.17 (dd, J = 10.2, 1.8 Hz,
1H), 5.11–4.98 (m, 3H), 4.68 (s, 2H), 3.65 (dt, J = 6.3, 3.3 Hz, 1H), 2.77–2.66 (m, 1H),
2.55–2.44 (m, 1H), 2.29–2.10 (m, 3H), 1.83–1.71 (m, 1H), 1.67–1.54 (m, 2H), 0.87 (s,
9H), 0.03 (s, 3H), 0.00 (s, 3H); 13C NMR (CDCl3, 75 MHz) δ 140.9, 139.0, 138.5, 135.8,
129.5, 128.3, 128.1, 126.3, 117.4, 117.0, 75.4, 63.2, 49.6, 39.4, 32.1, 30.5, 26.1 (3C),
18.3, –4.0, –4.3; IR (film) νmax 3332 (br), 3075, 2955, 2928, 2857, 1466, 1254, 1089,
914, 836, 775 cm–1; HRMS (FAB) m/z 383.2373 (MNa+, C22H36O2SiNa requires
383.2382).
SePh
O

OTBS

Se-Phenyl 2-(syn-4-(tert-butyldimethylsilyloxy)-3-vinylhept-6enyl)benzoselenoate (23). To a solution of oxalyl chloride (51 μL, 74 mg, 0.58 mmol)
in anhydrous CH2Cl2 (1.0 mL) under Ar at –78 ºC was added DMSO (80 μL, 88 mg, 1.13
mmol) in anhydrous CH2Cl2 (0.6 mL) dropwise. The solution was stirred under Ar at
–78 ºC for 15 min, then benzyl alcohol 76 (66 mg, 0.18 mmol) was added in anhydrous
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CH2Cl2 (0.5 mL + 2 × 0.5 mL rinses) and the resulting solution stirred under Ar at –78 ºC
for 80 min. Et3N (260 μL, 189 mg, 1.87 mmol) in anhydrous CH2Cl2 (0.6 mL) was then
added, and stirring continued as the mixture warmed from –78 ºC to +10 ºC over 2.5 h.
The reaction was then quenched with sat aq NaHCO3 (3 mL). The organic phase was
collected and the aqueous phase extracted with CH2Cl2 (3 × 3 mL). The combined
organics were dried (Na2SO4) and concentrated in vacuo to give the aldehyde (67 mg).
To a solution of the crude aldehyde in t-BuOH (2.0 mL) and H2O (0.5 mL) was
added successively 2-methyl-2-butene (0.24 mL, 156 mg, 2.23 mmol), NaH2PO4 (28 mg,
0.24 mmol), and NaOClO (102 mg, 1.13 mmol). The orange solution was stirred at rt
under Ar for 13 h and 45 min, after which it had faded to a clear solution. It was then
quenched with sat aq NH4Cl (3 mL) and extracted with CH2Cl2 (4 × 3 mL). The
combined extracts were dried (Na2SO4) and concentrated in vacuo to give the benzoic
acid (71 mg).
To a solution of the crude acid in anhydrous CH2Cl2 (1.8 mL) under Ar was added
PhSeSePh (0.28 mL of a 1.0 M solution in CH2Cl2, 0.28 mmol) and Bu3P (0.11 mL, 86
mg, 0.43 mmol) dropwise. The orange solution was stirred under Ar at rt for 5 h and 40
min, after which TLC analysis indicated incomplete conversion. More PhSeSePh (0.15
mL of a 1.0 M solution in CH2Cl2, 0.15 mmol) and Bu3P (75 μL, 62 mg, 0.30 mmol)
were added, and the solution stirred at rt under Ar for an additional 2.5 h, then quenched
with sat aq NH4Cl (3 mL). The organic phase was collected and the aqueous phase
extracted with CH2Cl2 (3 × 3 mL). The combined organics were dried (Na2SO4) and
concentrated in vacuo, then purified by flash chromatography (SiO2: 2.4 × 28 cm, 1%
Et2O in hexanes) to afford phenyl selenoester syn-23 (81 mg, 0.16 mmol, 87% over three
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steps) as a yellow oil: 1H NMR (CDCl3, 500 MHz) δ 7.82 (d, J = 8 Hz, 1H), 7.61–7.58
(m, 2H), 7.45–7.40 (m, 4H), 7.31 (t, J = 8.0 Hz, 1H), 7.27–7.23 (m, 1H), 5.75–5.66 (m,
2H), 5.13 (dd, J = 10.5, 2.0 Hz, 1H), 5.05–4.97 (m, 3H), 3.62 (dt, J = 6.5, 3.5 Hz, 1H),
2.88–2.82 (m, 1H), 2.67–2.60 (m, 1H), 2.24–2.08 (m, 3H), 1.81–1.72 (m, 1H), 1.66–1.57
(m, 1H), 0.85 (s, 9H), 0.01 (s, 3H), –0.02 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 195.6,
141.0, 139.0, 136.2 (2C), 135.7, 133.2, 132.1, 131.1, 129.6 (2C), 129.4, 129.1, 128.7,
126.2, 117.4, 117.0, 75.3, 49.3, 39.6, 32.6, 31.6, 26.1 (3C), 18.3, –4.0, –4.2; IR (film)
νmax 3073, 2954, 2928, 2856, 1703, 1477, 1254, 1090, 912, 836, 736 cm–1; HRMS (FAB)
m/z 537.1702 (MNa+, C28H38O2SeSiNa requires 537.1704).
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Acyl radical cascade cyclization product ((±)-24). Phenyl selenoester syn-23
(28 mg, 0.055 mmol) was dried azeotropically with anhydrous benzene (2 × 2.5 mL),
then dissolved in anhydrous benzene (12 mL) in a 3-neck round-bottom flask.
(TMS)3SiH (34 μL, 27 mg, 0.11 mmol) and Et3B (0.10 mL of a 1.0 M solution in
hexanes, 0.10 mmol) were added, and a constant supply of dry air was provided by
passing compressed air through a short tube of drierite and over the solution (venting
with a needle allowed a continuous flow). An additional portion of Et3B (1.0 mL of a 1.0
M solution in hexanes, 1.0 mmol) was added by syringe pump (0.13 mL/h, 8 h) while the
solution was stirred and exposed to dry air as explained above. Following the 8 h
addition period TLC analysis indicated incomplete conversion. More (TMS)3SiH (34 μL,
27 mg, 0.11 mmol) was added as well as another portion of Et3B (1.0 mL of a 1.0 M
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solution in hexanes, 1.0 mmol) by syringe pump (0.08 mL/h, 12.5 h) while the reaction
mixture was still exposed to dry air. The solution was stirred for an additional 3 h then
concentrated in vacuo. The residue was purified by flash chromatography (SiO2: 1.5 × 17
cm, 3% Et2O in hexanes) to afford (±)-24 (18 mg, 0.051 mmol, 93%) as a yellow oil: 1H
NMR (CDCl3, 500 MHz) δ 7.33 (dt, J = 7.5, 1.5 Hz, 1H), 7.24 (dt, J = 7.5, 1.0 Hz, 1H),
7.18 (d, J = 7.5 Hz, 1H), 7.14 (dd, J = 7.5, 1.5 Hz, 1H), 4.02 (br s, 1H), 2.79–2.69 (m,
3H), 2.53–2.46 (m, 1H), 2.44 (t, J = 12.5 Hz, 1H), 2.07–1.99 (m, 1H), 1.78–1.73 (m, 1H),
1.71–1.61 (m, 3H), 1.32–1.26 (m, 1H), 0.90 (d, J = 7.5 Hz, 3H), 0.86 (s, 9H), 0.02 (s,
3H), 0.01 (s, 3H); 13C NMR (CDCl3, 125 MHz) δ 212.4, 142.9, 138.2, 129.9, 129.6,
126.2, 123.5, 76.0, 51.3, 48.8, 43.2, 40.9, 34.6, 32.7, 31.4, 26.0 (3C), 18.3, 15.9, –4.4,
–4.8; 2D 1H–1H COSY NMR (CDCl3, 500 MHz) 4.02/1.71–1.61 (m, H-12/H-13ax),
4.02/1.32–1.26 (w, H-12/H-13eq), 2.79–2.69/2.44 (s, H-11/H-1), 2.79–2.69/1.78–1.73 (m,
H-9/H-10), 2.79–2.69/1.71–1.61 (m, H-9/H-10 and H-11/H10), 2.53–2.46/2.07–1.99 (m,
H-14/H-15ax), 2.53–2.46/1.71–1.61 (m, H-14/H-13eq), 2.53–2.46/1.32–1.26 (m,
H-14/H-13ax), 2.53–2.46/0.90 (s, H-14/H-16), 2.44/2.07–1.99 (m, H-1/H-15ax), 2.07–
1.99/1.71–1.61 (w, H-15ax/H-15eq), 1.78–1.73/1.71–1.61 (m, H-10ax/H-10eq), 1.71–
1.61/1.32–1.26 (s, H-13eq/H-13ax); 2D 1H–1H NOESY NMR (CDCl3, 500 MHz) 2.79–
2.69/2.44 (s, H-11ax/H-1ax), 2.79–2.69/2.07–1.99 (w, H-11ax/H-15ax), 2.79–2.69/1.78–
1.73 (w, H-10/H-9), 2.44/2.07–1.99 (w, H-1ax/H-15ax), 1.78–1.73/1.32–1.26 (m,
H-13ax/H-13eq); IR (film) νmax 2955, 2930, 2857, 1696, 1461, 1254, 1113, 1061, 910,
836, 735 cm–1; HRMS (FAB) m/z 359.2405 (MH+, C22H35O2Si requires 359.2406).
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5.4 Selected NMR Spectra
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